UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number 811-21990
Fidelity Commonwealth Trust II
(Exact name of registrant as specified in charter)
245 Summer St., Boston, Massachusetts 02210
(Address of principal executive offices) (Zip code)
Cynthia Lo Bessette, Secretary
245 Summer St.
Boston, Massachusetts 02210
(Name and address of agent for service)
Registrant's telephone number, including area code:
617-563-7000
Date of fiscal year end: |
February 29 |
|
|
Date of reporting period: |
February 29, 2020 |
Item 1.
Reports to Stockholders
Fidelity® Small Cap Enhanced Index Fund
February 29, 2020
Beginning on January 1, 2021, as permitted by regulations adopted by the Securities and Exchange Commission, paper copies of a funds shareholder reports will no longer be sent by mail, unless you specifically request paper copies of the reports from the fund or from your financial intermediary, such as a financial advisor, broker-dealer or bank. Instead, the reports will be made available on a website, and you will be notified by mail each time a report is posted and provided with a website link to access the report.
If you already elected to receive shareholder reports electronically, you will not be affected by this change and you need not take any action. You may elect to receive shareholder reports and other communications from a fund electronically, by contacting your financial intermediary. For Fidelity customers, visit Fidelity's web site or call Fidelity using the contact information listed below.
You may elect to receive all future reports in paper free of charge. If you wish to continue receiving paper copies of your shareholder reports, you may contact your financial intermediary or, if you are a Fidelity customer, visit Fidelitys website, or call Fidelity at the applicable toll-free number listed below. Your election to receive reports in paper will apply to all funds held with the fund complex/your financial intermediary.
Account Type | Website | Phone Number |
Brokerage, Mutual Fund, or Annuity Contracts: | fidelity.com/mailpreferences | 1-800-343-3548 |
Employer Provided Retirement Accounts: | netbenefits.fidelity.com/preferences (choose 'no' under Required Disclosures to continue to print) | 1-800-343-0860 |
Advisor Sold Accounts Serviced Through Your Financial Intermediary: | Contact Your Financial Intermediary | Your Financial Intermediary's phone number |
Advisor Sold Accounts Serviced by Fidelity: | institutional.fidelity.com | 1-877-208-0098 |
Contents
Board Approval of Investment Advisory Contracts and Management Fees |
|
To view a fund's proxy voting guidelines and proxy voting record for the 12-month period ended June 30, visit http://www.fidelity.com/proxyvotingresults or visit the Securities and Exchange Commission's (SEC) web site at http://www.sec.gov.
You may also call 1-800-544-8544 to request a free copy of the proxy voting guidelines.
Standard & Poor's, S&P and S&P 500 are registered service marks of The McGraw-Hill Companies, Inc. and have been licensed for use by Fidelity Distributors Corporation.
Other third-party marks appearing herein are the property of their respective owners.
All other marks appearing herein are registered or unregistered trademarks or service marks of FMR LLC or an affiliated company. © 2020 FMR LLC. All rights reserved.
This report and the financial statements contained herein are submitted for the general information of the shareholders of the Fund. This report is not authorized for distribution to prospective investors in the Fund unless preceded or accompanied by an effective prospectus.
A fund files its complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year on Form N-PORT. Forms N-PORT are available on the SECs web site at http://www.sec.gov. A fund's Forms N-PORT may be reviewed and copied at the SECs Public Reference Room in Washington, DC. Information regarding the operation of the SEC's Public Reference Room may be obtained by calling 1-800-SEC-0330.
For a complete list of a fund's portfolio holdings, view the most recent holdings listing, semiannual report, or annual report on Fidelity's web site at http://www.fidelity.com, http://www.institutional.fidelity.com, or http://www.401k.com, as applicable.
NOT FDIC INSURED MAY LOSE VALUE NO BANK GUARANTEE
Neither the Fund nor Fidelity Distributors Corporation is a bank.
Note to Shareholders:
Early in 2020, the outbreak and spread of a new coronavirus emerged as a public health emergency that had a major influence on financial markets, primarily based on its impact on the global economy and corporate earnings. The virus causes a respiratory disease known as COVID-19. On March 11, the World Health Organization declared the COVID-19 outbreak a pandemic, citing sustained risk of further global spread.
In the weeks following the end of this reporting period, as the crisis worsened, we witnessed an escalating human tragedy with wide-scale social and economic consequences from coronavirus-containment measures. The outbreak of COVID-19 prompted a number of measures to limit the spread, including travel and border restrictions, quarantines, and restrictions on large gatherings. In turn, these resulted in lower consumer activity, diminished demand for a wide range of products and services, disruption in manufacturing and supply chains, and given the wide variability in outcomes regarding the outbreak significant market uncertainty and volatility. Amid the turmoil, the U.S. government took unprecedented action in concert with the U.S. Federal Reserve and central banks around the world to help support consumers, businesses, and the broader economy, and to limit disruption to the financial system.
The situation continues to unfold, and the extent and duration of its impact on financial markets and the economy remain highly uncertain. Extreme events such as the coronavirus crisis are exogenous shocks that can have significant adverse effects on mutual funds and their investments. Although multiple asset classes may be affected by market disruption, the duration and impact may not be the same for all types of assets.
Fidelity is committed to helping you stay informed amid news about COVID-19 and during increased market volatility, and were taking extra steps to be responsive to customer needs. We encourage you to visit our websites, where we offer ongoing updates, commentary, and analysis on the markets and our funds.
Performance: The Bottom Line
Average annual total return reflects the change in the value of an investment, assuming reinvestment of distributions from dividend income and capital gains (the profits earned upon the sale of securities that have grown in value, if any) and assuming a constant rate of performance each year. The hypothetical investment and the average annual total returns do not reflect the deduction of taxes that a shareholder would pay on fund distributions or the redemption of fund shares. During periods of reimbursement by Fidelity, a funds total return will be greater than it would be had the reimbursement not occurred. How a fund did yesterday is no guarantee of how it will do tomorrow.
Average Annual Total Returns
For the periods ended February 29, 2020 | Past 1 year | Past 5 years | Past 10 years |
Fidelity® Small Cap Enhanced Index Fund | (9.18)% | 2.92% | 10.11% |
$10,000 Over 10 Years
Let's say hypothetically that $10,000 was invested in Fidelity® Small Cap Enhanced Index Fund on February 28, 2010.
The chart shows how the value of your investment would have changed, and also shows how the Russell 2000® Index performed over the same period.
Period Ending Values | ||
|
$26,195 | Fidelity® Small Cap Enhanced Index Fund |
|
$26,932 | Russell 2000® Index |
Management's Discussion of Fund Performance
Comments from Maximilian Kaufmann, Senior Portfolio Manager of the Geode Capital Management, LLC, investment management team: For the fiscal year, the fund returned -9.18%, trailing the -4.92% result of the benchmark Russell 2000® Index. Security selection in the real estate, consumer discretionary, health care and industrials sectors all were negative factors behind the fund's relative underperformance. Individually, the portfolio's biggest negative was Liberty TripAdvisor Holdings (-71%), a provider of online travel information that reported poor financial results amid increased competition. Another challenge for relative performance was RMR Group (-46%), an owner of various real estate businesses. The company's diverse real estate portfolio includes various owners of retail, lodging and senior-housing facilities three lagging areas of the commercial property market the 12 months. Further detracting was the fund's untimely positioning in Coca-Cola Bottling Co. Consolidated (-50%), a maker, seller and distributor of Coca-Cola products, along with virtual health-care-services provider Teladoc Health (+51%), a strong-performing benchmark component to which the fund lacked any exposure for the vast majority of the reporting period. On the positive side, the fund was well positioned in the lagging energy sector, where both stock picking and a helpful underweighting added value. The portfolio's biggest individual contributor was Synaptics (+58%), a maker of computer touchpads and other electronic interfaces. Much of the firm's share-price gain came in February, after the company reported better-than-anticipated profits and revenue. Another key contributor was Atkore International Group (+60%). Strong financial results boosted this maker of products related to electrical wiring. Also adding value was semiconductor manufacturer Cirrus Logic (+71%), which generated strong financial results on healthy demand for its specialized chips.
The views expressed above reflect those of the portfolio manager(s) only through the end of the period as stated on the cover of this report and do not necessarily represent the views of Fidelity or any other person in the Fidelity organization. Any such views are subject to change at any time based upon market or other conditions and Fidelity disclaims any responsibility to update such views. These views may not be relied on as investment advice and, because investment decisions for a Fidelity fund are based on numerous factors, may not be relied on as an indication of trading intent on behalf of any Fidelity fund.
Investment Summary (Unaudited)
Top Ten Stocks as of February 29, 2020
% of fund's net assets | |
Haemonetics Corp. | 0.8 |
Deckers Outdoor Corp. | 0.8 |
Generac Holdings, Inc. | 0.8 |
Portland General Electric Co. | 0.8 |
EMCOR Group, Inc. | 0.7 |
Amedisys, Inc. | 0.7 |
Tandem Diabetes Care, Inc. | 0.7 |
Box, Inc. Class A | 0.7 |
Essent Group Ltd. | 0.7 |
Cirrus Logic, Inc. | 0.7 |
7.4 |
Top Market Sectors as of February 29, 2020
% of fund's net assets | |
Health Care | 20.4 |
Financials | 17.4 |
Industrials | 17.1 |
Information Technology | 14.4 |
Consumer Discretionary | 10.1 |
Real Estate | 6.4 |
Materials | 4.2 |
Utilities | 2.9 |
Consumer Staples | 2.5 |
Communication Services | 2.4 |
Asset Allocation (% of fund's net assets)
As of February 29, 2020* | ||
Stocks and Equity Futures | 99.8% | |
Short-Term Investments and Net Other Assets (Liabilities) | 0.2% |
* Foreign investments - 4.8%
Schedule of Investments February 29, 2020
Showing Percentage of Net Assets
Common Stocks - 98.7% | |||
Shares | Value | ||
COMMUNICATION SERVICES - 2.4% | |||
Diversified Telecommunication Services - 0.8% | |||
Cogent Communications Group, Inc. | 49,139 | $3,587,638 | |
Consolidated Communications Holdings, Inc. | 38,170 | 237,417 | |
Iridium Communications, Inc. (a) | 2,697 | 73,008 | |
Ooma, Inc. (a) | 21,796 | 279,643 | |
4,177,706 | |||
Entertainment - 0.0% | |||
Glu Mobile, Inc. (a) | 19,412 | 138,213 | |
Interactive Media & Services - 1.0% | |||
CarGurus, Inc. Class A (a)(b) | 45,216 | 1,152,556 | |
EverQuote, Inc. Class A (a)(b) | 5,361 | 217,764 | |
Liberty TripAdvisor Holdings, Inc. (a) | 42,084 | 183,276 | |
Yelp, Inc. (a) | 104,767 | 3,276,064 | |
Zedge, Inc. (a) | 19,804 | 28,755 | |
4,858,415 | |||
Media - 0.4% | |||
A.H. Belo Corp. Class A | 5,107 | 12,768 | |
Cardlytics, Inc. (a) | 12,948 | 1,027,942 | |
Emerald Expositions Events, Inc. (b) | 11,235 | 77,072 | |
Lee Enterprises, Inc. (a)(b) | 2,736 | 4,104 | |
MSG Network, Inc. Class A (a) | 49,914 | 630,913 | |
National CineMedia, Inc. | 1,868 | 14,365 | |
TechTarget, Inc. (a) | 18,282 | 422,863 | |
2,190,027 | |||
Wireless Telecommunication Services - 0.2% | |||
Shenandoah Telecommunications Co. | 25,442 | 1,130,388 | |
TOTAL COMMUNICATION SERVICES | 12,494,749 | ||
CONSUMER DISCRETIONARY - 10.1% | |||
Auto Components - 0.3% | |||
Adient PLC (a) | 37,532 | 898,141 | |
Modine Manufacturing Co. (a) | 8,210 | 61,247 | |
Visteon Corp. (a)(b) | 6,236 | 405,589 | |
1,364,977 | |||
Distributors - 0.1% | |||
Core-Mark Holding Co., Inc. | 20,572 | 473,362 | |
Diversified Consumer Services - 0.2% | |||
American Public Education, Inc. (a) | 7,330 | 163,166 | |
Collectors Universe, Inc. | 12,674 | 291,565 | |
Weight Watchers International, Inc. (a) | 23,563 | 706,890 | |
1,161,621 | |||
Hotels, Restaurants & Leisure - 1.5% | |||
Bloomin' Brands, Inc. | 88,427 | 1,590,802 | |
Brinker International, Inc. (b) | 63,290 | 2,174,012 | |
Dine Brands Global, Inc. | 3,094 | 253,244 | |
Everi Holdings, Inc. (a) | 189,188 | 1,967,555 | |
Jack in the Box, Inc. | 251 | 17,284 | |
RCI Hospitality Holdings, Inc. | 21,028 | 423,714 | |
Scientific Games Corp. Class A (a) | 58,292 | 1,063,246 | |
The Cheesecake Factory, Inc. (b) | 12,494 | 445,161 | |
7,935,018 | |||
Household Durables - 3.3% | |||
Bassett Furniture Industries, Inc. | 2,379 | 23,481 | |
Cavco Industries, Inc. (a) | 8,948 | 1,804,991 | |
Ethan Allen Interiors, Inc. | 51,769 | 683,351 | |
Flexsteel Industries, Inc. | 20,975 | 288,197 | |
Installed Building Products, Inc. (a) | 3,200 | 211,360 | |
KB Home | 102,992 | 3,356,509 | |
La-Z-Boy, Inc. | 62,588 | 1,793,146 | |
M.D.C. Holdings, Inc. | 40,654 | 1,599,328 | |
M/I Homes, Inc. (a) | 76,614 | 2,852,339 | |
Meritage Homes Corp. (a) | 7,699 | 488,579 | |
Taylor Morrison Home Corp. (a) | 85,852 | 1,933,387 | |
TopBuild Corp. (a) | 642 | 64,842 | |
TRI Pointe Homes, Inc. (a) | 109,424 | 1,677,470 | |
16,776,980 | |||
Internet & Direct Marketing Retail - 0.2% | |||
Shutterstock, Inc. | 33,078 | 1,274,826 | |
Leisure Products - 0.3% | |||
Acushnet Holdings Corp. | 7,328 | 186,498 | |
Johnson Outdoors, Inc. Class A (b) | 17,253 | 1,076,760 | |
Malibu Boats, Inc. Class A (a) | 3,597 | 158,052 | |
1,421,310 | |||
Specialty Retail - 2.9% | |||
Asbury Automotive Group, Inc. (a)(b) | 11,392 | 1,009,787 | |
Group 1 Automotive, Inc. | 28,103 | 2,395,219 | |
Haverty Furniture Companies, Inc. | 54,804 | 921,803 | |
Office Depot, Inc. | 381,061 | 895,493 | |
Rent-A-Center, Inc. | 73,303 | 1,560,621 | |
RH (a) | 1,023 | 185,572 | |
Sally Beauty Holdings, Inc. (a)(b) | 160,869 | 2,001,210 | |
Shoe Carnival, Inc. (b) | 44,670 | 1,336,080 | |
Signet Jewelers Ltd. | 50,977 | 1,188,784 | |
Sleep Number Corp. (a) | 51,893 | 2,285,887 | |
Sonic Automotive, Inc. Class A (sub. vtg.) | 44,447 | 1,244,516 | |
15,024,972 | |||
Textiles, Apparel & Luxury Goods - 1.3% | |||
Crocs, Inc. (a) | 57,200 | 1,496,924 | |
Deckers Outdoor Corp. (a) | 23,739 | 4,125,838 | |
Rocky Brands, Inc. | 9,809 | 238,849 | |
Steven Madden Ltd. | 25,631 | 838,134 | |
Vera Bradley, Inc. (a) | 23,134 | 191,087 | |
6,890,832 | |||
TOTAL CONSUMER DISCRETIONARY | 52,323,898 | ||
CONSUMER STAPLES - 2.5% | |||
Beverages - 1.2% | |||
Boston Beer Co., Inc. Class A (a) | 9,435 | 3,498,404 | |
Coca-Cola Bottling Co. Consolidated | 12,348 | 2,424,900 | |
5,923,304 | |||
Food & Staples Retailing - 0.5% | |||
BJ's Wholesale Club Holdings, Inc. (a) | 11,228 | 216,251 | |
Ingles Markets, Inc. Class A | 51,631 | 1,846,841 | |
Natural Grocers by Vitamin Cottage, Inc. (b) | 27,741 | 191,413 | |
Performance Food Group Co. (a) | 2,844 | 120,586 | |
Village Super Market, Inc. Class A (b) | 1,423 | 29,243 | |
Weis Markets, Inc. (b) | 6,852 | 255,237 | |
2,659,571 | |||
Food Products - 0.3% | |||
Freshpet, Inc. (a) | 9,009 | 598,738 | |
John B. Sanfilippo & Son, Inc. | 7,146 | 501,578 | |
The Simply Good Foods Co. (a) | 12,093 | 266,772 | |
1,367,088 | |||
Personal Products - 0.3% | |||
USANA Health Sciences, Inc. (a) | 22,490 | 1,486,589 | |
Tobacco - 0.2% | |||
Vector Group Ltd. | 106,611 | 1,238,820 | |
TOTAL CONSUMER STAPLES | 12,675,372 | ||
ENERGY - 0.9% | |||
Energy Equipment & Services - 0.2% | |||
Archrock, Inc. | 102,607 | 723,379 | |
ProPetro Holding Corp. (a) | 25,308 | 221,698 | |
945,077 | |||
Oil, Gas & Consumable Fuels - 0.7% | |||
Delek U.S. Holdings, Inc. | 18,978 | 405,750 | |
DHT Holdings, Inc. | 233,060 | 1,293,483 | |
Evolution Petroleum Corp. | 4,916 | 23,154 | |
Falcon Minerals Corp. | 14,911 | 59,569 | |
GasLog Ltd. | 109,937 | 616,747 | |
Nordic American Tanker Shipping Ltd. | 190,587 | 613,690 | |
Teekay Tankers Ltd. (a) | 30,287 | 501,250 | |
W&T Offshore, Inc. (a) | 89,228 | 231,993 | |
World Fuel Services Corp. | 5,679 | 160,602 | |
3,906,238 | |||
TOTAL ENERGY | 4,851,315 | ||
FINANCIALS - 17.4% | |||
Banks - 6.6% | |||
1st Source Corp. | 14,649 | 615,990 | |
BancFirst Corp. | 57,639 | 2,956,881 | |
Bancorp, Inc., Delaware (a) | 14,688 | 178,753 | |
Boston Private Financial Holdings, Inc. | 23,226 | 226,570 | |
Brookline Bancorp, Inc., Delaware | 7,519 | 104,289 | |
Cadence Bancorp Class A | 70,401 | 994,062 | |
Capital City Bank Group, Inc. | 3,745 | 99,804 | |
Cathay General Bancorp (b) | 100,524 | 3,094,129 | |
Centerstate Banks of Florida, Inc. | 9,122 | 184,538 | |
Codorus Valley Bancorp, Inc. | 433 | 8,920 | |
Community Bank System, Inc. | 4,433 | 269,571 | |
Community Trust Bancorp, Inc. | 11,647 | 450,506 | |
Financial Institutions, Inc. | 18,467 | 496,947 | |
First Bancorp, North Carolina (b) | 2,519 | 80,860 | |
First Bancorp, Puerto Rico | 352,341 | 2,797,588 | |
First Interstate Bancsystem, Inc. | 34,333 | 1,169,382 | |
Fulton Financial Corp. (b) | 228,375 | 3,300,019 | |
Great Southern Bancorp, Inc. | 29,244 | 1,500,510 | |
Hancock Whitney Corp. | 79,192 | 2,652,932 | |
HBT Financial, Inc. | 2,175 | 33,669 | |
Hilltop Holdings, Inc. | 6,489 | 135,166 | |
Hope Bancorp, Inc. | 18,073 | 220,671 | |
IBERIABANK Corp. | 6,394 | 384,855 | |
International Bancshares Corp. | 90,725 | 3,093,723 | |
Investors Bancorp, Inc. | 318,680 | 3,358,887 | |
Lakeland Bancorp, Inc. | 8,387 | 120,815 | |
National Bankshares, Inc. | 467 | 16,322 | |
OFG Bancorp | 47,911 | 802,030 | |
Old National Bancorp, Indiana | 10,014 | 157,821 | |
Peapack-Gladstone Financial Corp. | 13,574 | 372,606 | |
Peoples Bancorp, Inc. | 2,599 | 74,201 | |
Republic Bancorp, Inc., Kentucky Class A | 6,011 | 214,833 | |
Sandy Spring Bancorp, Inc. | 9,418 | 289,698 | |
Sierra Bancorp | 14,292 | 340,435 | |
South Plains Financial, Inc. | 428 | 8,573 | |
The Bank of NT Butterfield & Son Ltd. | 22,330 | 618,094 | |
Trustmark Corp. | 7,556 | 203,256 | |
UMB Financial Corp. | 24,727 | 1,437,875 | |
Univest Corp. of Pennsylvania | 7,501 | 175,523 | |
WesBanco, Inc. | 27,387 | 838,316 | |
34,079,620 | |||
Capital Markets - 3.4% | |||
Ares Management Corp. | 7,548 | 261,085 | |
Artisan Partners Asset Management, Inc. | 100,727 | 2,878,778 | |
Cohen & Steers, Inc. | 47,195 | 2,956,767 | |
Federated Hermes, Inc. Class B (non-vtg.) | 113,233 | 3,266,772 | |
Houlihan Lokey | 17,011 | 871,303 | |
INTL FCStone, Inc. (a) | 34,734 | 1,582,134 | |
Oppenheimer Holdings, Inc. Class A (non-vtg.) | 36,094 | 856,511 | |
Piper Jaffray Companies (b) | 23,303 | 1,633,074 | |
Pzena Investment Management, Inc. | 7,542 | 49,249 | |
Silvercrest Asset Management Group Class A | 852 | 9,849 | |
Stifel Financial Corp. | 4,223 | 229,900 | |
Virtus Investment Partners, Inc. | 1,112 | 122,765 | |
Waddell & Reed Financial, Inc. Class A (b) | 201,720 | 2,775,667 | |
Westwood Holdings Group, Inc. | 1,901 | 48,247 | |
17,542,101 | |||
Consumer Finance - 1.0% | |||
Enova International, Inc. (a) | 127,725 | 2,454,875 | |
LendingClub Corp. (a) | 2,859 | 31,478 | |
Nelnet, Inc. Class A | 47,772 | 2,536,693 | |
5,023,046 | |||
Diversified Financial Services - 0.8% | |||
Cannae Holdings, Inc. (a) | 94,039 | 3,506,714 | |
Marlin Business Services Corp. | 30,934 | 608,162 | |
4,114,876 | |||
Insurance - 2.8% | |||
Amerisafe, Inc. | 21,296 | 1,387,860 | |
Crawford & Co. Class B | 5,563 | 37,995 | |
eHealth, Inc. (a) | 17,721 | 2,079,559 | |
Employers Holdings, Inc. | 10,695 | 412,185 | |
Genworth Financial, Inc. Class A | 5,803 | 22,632 | |
Goosehead Insurance (b) | 54,557 | 2,959,172 | |
Hallmark Financial Services, Inc. (a) | 2,704 | 38,343 | |
Horace Mann Educators Corp. | 43,693 | 1,700,968 | |
Investors Title Co. | 513 | 84,111 | |
National General Holdings Corp. | 36,449 | 709,662 | |
RLI Corp. | 3,278 | 263,486 | |
Selective Insurance Group, Inc. | 49,201 | 2,744,432 | |
Trupanion, Inc. (a)(b) | 66,073 | 2,031,084 | |
14,471,489 | |||
Mortgage Real Estate Investment Trusts - 0.1% | |||
Invesco Mortgage Capital, Inc. | 8,453 | 135,924 | |
Ladder Capital Corp. Class A | 30,125 | 459,406 | |
595,330 | |||
Thrifts & Mortgage Finance - 2.7% | |||
Essent Group Ltd. | 86,618 | 3,780,010 | |
Farmer Mac Class C (non-vtg.) | 12,816 | 961,969 | |
First Defiance Financial Corp. | 13,813 | 330,338 | |
Northwest Bancshares, Inc. (b) | 127,898 | 1,776,503 | |
Pennymac Financial Services, Inc. | 729 | 25,705 | |
Radian Group, Inc. | 163,532 | 3,473,420 | |
Walker & Dunlop, Inc. | 29,084 | 1,886,097 | |
Washington Federal, Inc. | 38,176 | 1,144,898 | |
Waterstone Financial, Inc. | 38,943 | 647,622 | |
14,026,562 | |||
TOTAL FINANCIALS | 89,853,024 | ||
HEALTH CARE - 20.4% | |||
Biotechnology - 8.1% | |||
ACADIA Pharmaceuticals, Inc. (a) | 39,857 | 1,703,488 | |
Acceleron Pharma, Inc. (a) | 9,954 | 855,347 | |
Adverum Biotechnologies, Inc. (a) | 18,818 | 231,650 | |
Affimed NV (a) | 130,575 | 308,157 | |
Aimmune Therapeutics, Inc. (a)(b) | 4,310 | 102,621 | |
Akebia Therapeutics, Inc. (a) | 71,235 | 631,854 | |
Aldeyra Therapeutics, Inc. (a) | 10,850 | 41,230 | |
Allakos, Inc. (a)(b) | 7,715 | 480,876 | |
Allogene Therapeutics, Inc. (a) | 722 | 19,494 | |
Amicus Therapeutics, Inc. (a) | 47,700 | 455,297 | |
Apellis Pharmaceuticals, Inc. (a) | 21,342 | 738,860 | |
Applied Therapeutics, Inc. (a) | 8,936 | 371,291 | |
Ardelyx, Inc. (a) | 77,565 | 536,750 | |
Arena Pharmaceuticals, Inc. (a) | 10,362 | 462,145 | |
Arrowhead Pharmaceuticals, Inc. (a) | 18,973 | 670,885 | |
Athenex, Inc. (a)(b) | 17,314 | 211,577 | |
Avid Bioservices, Inc. (a) | 18,551 | 116,871 | |
Biohaven Pharmaceutical Holding Co. Ltd. (a) | 6,301 | 278,252 | |
Biospecifics Technologies Corp. (a) | 1,868 | 103,095 | |
BioXcel Therapeutics, Inc. (a)(b) | 10,691 | 400,913 | |
Blueprint Medicines Corp. (a) | 10,372 | 561,436 | |
Castle Biosciences, Inc. (b) | 4,128 | 123,592 | |
Catalyst Pharmaceutical Partners, Inc. (a) | 113,153 | 476,374 | |
Cel-Sci Corp. (a)(b) | 9,403 | 103,151 | |
ChemoCentryx, Inc. (a) | 6,141 | 274,810 | |
Chimerix, Inc. (a) | 127,518 | 225,707 | |
Coherus BioSciences, Inc. (a) | 35,164 | 680,423 | |
Constellation Pharmaceuticals, Inc. (a)(b) | 12,893 | 455,639 | |
Cortexyme, Inc. | 5,865 | 294,716 | |
Cue Biopharma, Inc. (a) | 5,742 | 100,428 | |
Cyclerion Therapeutics, Inc. (a)(b) | 3,819 | 16,345 | |
CytomX Therapeutics, Inc. (a) | 11,690 | 78,206 | |
Deciphera Pharmaceuticals, Inc. (a) | 14,037 | 747,330 | |
Denali Therapeutics, Inc. (a)(b) | 3,187 | 63,007 | |
Dicerna Pharmaceuticals, Inc. (a) | 6,374 | 125,823 | |
Eagle Pharmaceuticals, Inc. (a) | 3,772 | 173,135 | |
Editas Medicine, Inc. (a)(b) | 5,396 | 119,683 | |
Eidos Therapeutics, Inc. (a)(b) | 4,342 | 219,618 | |
Emergent BioSolutions, Inc. (a) | 18,754 | 1,100,485 | |
Epizyme, Inc. (a) | 10,854 | 232,601 | |
Esperion Therapeutics, Inc. (a)(b) | 2,038 | 102,899 | |
Fate Therapeutics, Inc. (a) | 27,633 | 806,884 | |
FibroGen, Inc. (a) | 28,091 | 1,174,204 | |
Forty Seven, Inc. (a) | 14,775 | 856,950 | |
Global Blood Therapeutics, Inc. (a) | 13,132 | 839,923 | |
Halozyme Therapeutics, Inc. (a) | 63,757 | 1,247,724 | |
Heron Therapeutics, Inc. (a)(b) | 11,877 | 221,506 | |
IGM Biosciences, Inc. (a) | 5,330 | 274,015 | |
ImmunoGen, Inc. (a) | 130,039 | 578,674 | |
Immunomedics, Inc. (a) | 35,565 | 569,040 | |
Insmed, Inc. (a) | 16,396 | 408,260 | |
Intercept Pharmaceuticals, Inc. (a) | 4,868 | 447,564 | |
Invitae Corp. (a)(b) | 41,415 | 844,038 | |
Iovance Biotherapeutics, Inc. (a) | 45,674 | 1,503,131 | |
Ironwood Pharmaceuticals, Inc. Class A (a) | 20,664 | 248,795 | |
Kadmon Holdings, Inc. (a) | 100,825 | 467,828 | |
Karuna Therapeutics, Inc. (a) | 4,342 | 378,883 | |
Karyopharm Therapeutics, Inc. (a) | 806 | 13,170 | |
Kodiak Sciences, Inc. (a)(b) | 11,606 | 742,436 | |
Krystal Biotech, Inc. (a)(b) | 6,007 | 321,074 | |
Kura Oncology, Inc. (a) | 7,583 | 91,527 | |
Ligand Pharmaceuticals, Inc. Class B (a)(b) | 6,574 | 615,326 | |
Mirati Therapeutics, Inc. (a)(b) | 10,185 | 911,456 | |
Molecular Templates, Inc. (a) | 16,907 | 272,034 | |
Momenta Pharmaceuticals, Inc. (a) | 37,852 | 1,070,833 | |
Myriad Genetics, Inc. (a) | 23,163 | 408,132 | |
Natera, Inc. (a) | 28,203 | 1,069,035 | |
NextCure, Inc. | 2,264 | 94,545 | |
Oncternal Therapeutics, Inc. rights (a)(c) | 1,148 | 0 | |
Opko Health, Inc. (a)(b) | 243,234 | 364,851 | |
Organogenesis Holdings, Inc. Class A (a) | 13,786 | 54,041 | |
Oyster Point Pharma, Inc. (a) | 6,241 | 220,994 | |
Pfenex, Inc. (a) | 32,253 | 374,135 | |
Pieris Pharmaceuticals, Inc. (a) | 13 | 40 | |
Portola Pharmaceuticals, Inc. (a)(b) | 25,185 | 254,620 | |
Principia Biopharma, Inc. (a) | 12,788 | 825,593 | |
PTC Therapeutics, Inc. (a) | 24,574 | 1,347,638 | |
Puma Biotechnology, Inc. (a)(b) | 31,110 | 334,588 | |
Radius Health, Inc. (a) | 27,709 | 583,552 | |
RAPT Therapeutics, Inc. (a)(b) | 5,438 | 107,509 | |
Recro Pharma, Inc. (a) | 23,376 | 335,212 | |
REGENXBIO, Inc. (a) | 9,200 | 368,000 | |
Repligen Corp. (a) | 12,057 | 1,032,079 | |
Retrophin, Inc. (a) | 33,351 | 516,774 | |
Syndax Pharmaceuticals, Inc. (a) | 16,451 | 154,804 | |
TG Therapeutics, Inc. (a)(b) | 44,214 | 554,886 | |
Turning Point Therapeutics, Inc. | 3,189 | 158,079 | |
Ultragenyx Pharmaceutical, Inc. (a)(b) | 10,247 | 574,652 | |
Vanda Pharmaceuticals, Inc. (a) | 37,485 | 413,460 | |
Veracyte, Inc. (a) | 28,374 | 700,554 | |
Vericel Corp. (a) | 16,264 | 251,116 | |
Viela Bio, Inc. (b) | 2,608 | 113,813 | |
Xbiotech, Inc. (a)(b) | 21,030 | 257,828 | |
Xencor, Inc. (a) | 5,180 | 168,298 | |
41,540,164 | |||
Health Care Equipment & Supplies - 4.8% | |||
Cardiovascular Systems, Inc. (a) | 71,137 | 2,676,174 | |
ConforMis, Inc. (a) | 201,182 | 156,761 | |
Cutera, Inc. (a) | 5,048 | 125,089 | |
Haemonetics Corp. (a) | 40,146 | 4,349,002 | |
Integer Holdings Corp. (a) | 40,495 | 3,651,434 | |
Invacare Corp. | 34,214 | 259,342 | |
Lantheus Holdings, Inc. (a) | 55,889 | 869,074 | |
LeMaitre Vascular, Inc. | 4,920 | 140,220 | |
Meridian Bioscience, Inc. | 158,652 | 1,267,629 | |
Nevro Corp. (a) | 8,790 | 1,144,019 | |
Novocure Ltd. (a) | 28,246 | 2,054,897 | |
Orthofix International NV (a) | 41,325 | 1,460,426 | |
Seaspine Holdings Corp. (a) | 24,285 | 343,147 | |
Shockwave Medical, Inc. (a) | 401 | 16,096 | |
SurModics, Inc. (a) | 52,987 | 1,849,776 | |
Tandem Diabetes Care, Inc. (a) | 51,108 | 3,815,723 | |
Wright Medical Group NV (a) | 15,918 | 481,520 | |
24,660,329 | |||
Health Care Providers & Services - 3.6% | |||
Amedisys, Inc. (a) | 21,954 | 3,820,216 | |
Apollo Medical Holdings, Inc. (a)(b) | 29,276 | 511,452 | |
Brookdale Senior Living, Inc. (a) | 34,943 | 229,576 | |
Corvel Corp. (a) | 36,358 | 2,506,521 | |
Exagen, Inc. (a)(b) | 4,062 | 69,379 | |
Magellan Health Services, Inc. (a) | 16,326 | 979,723 | |
National Healthcare Corp. | 39,933 | 2,963,428 | |
Patterson Companies, Inc. | 20,711 | 492,715 | |
Pennant Group, Inc. (a) | 5,910 | 160,575 | |
Providence Service Corp. (a) | 19,279 | 1,191,057 | |
Select Medical Holdings Corp. (a) | 106,206 | 2,542,572 | |
Tenet Healthcare Corp. (a) | 113,823 | 2,991,268 | |
U.S. Physical Therapy, Inc. | 2,731 | 284,625 | |
18,743,107 | |||
Health Care Technology - 1.6% | |||
Allscripts Healthcare Solutions, Inc. (a) | 346,441 | 2,612,165 | |
HealthStream, Inc. (a) | 17,752 | 431,729 | |
HMS Holdings Corp. (a) | 57,311 | 1,316,434 | |
Nextgen Healthcare, Inc. (a) | 171,878 | 2,248,164 | |
Teladoc Health, Inc. (a)(b) | 13,370 | 1,670,715 | |
8,279,207 | |||
Life Sciences Tools & Services - 0.7% | |||
Fluidigm Corp. (a) | 15,934 | 52,901 | |
Luminex Corp. | 24,185 | 598,821 | |
Medpace Holdings, Inc. (a) | 12,987 | 1,168,051 | |
Nanostring Technologies, Inc. (a) | 16,435 | 586,072 | |
NeoGenomics, Inc. (a) | 18,314 | 518,836 | |
Syneos Health, Inc. (a) | 13,087 | 829,061 | |
3,753,742 | |||
Pharmaceuticals - 1.6% | |||
Akorn, Inc. (a) | 190,664 | 221,170 | |
Amneal Pharmaceuticals, Inc. (a) | 77,167 | 297,093 | |
Arvinas Holding Co. LLC (a) | 571 | 26,911 | |
Assertio Therapeutics, Inc. (a) | 59,586 | 64,353 | |
Axsome Therapeutics, Inc. (a)(b) | 10,328 | 805,584 | |
Baudax Bio, Inc. (a)(b) | 3,168 | 22,113 | |
Collegium Pharmaceutical, Inc. (a) | 21,433 | 509,034 | |
Corcept Therapeutics, Inc. (a)(b) | 32,444 | 409,443 | |
Endo International PLC (a) | 133,698 | 738,013 | |
Intra-Cellular Therapies, Inc. (a) | 4,918 | 103,770 | |
Mallinckrodt PLC (a)(b) | 134,030 | 573,648 | |
MyoKardia, Inc. (a) | 8,731 | 553,458 | |
NGM Biopharmaceuticals, Inc. (b) | 3,244 | 58,522 | |
Pacira Biosciences, Inc. (a) | 19,907 | 863,566 | |
Phibro Animal Health Corp. Class A | 19,998 | 504,950 | |
Prestige Brands Holdings, Inc. (a) | 27,615 | 1,031,696 | |
Reata Pharmaceuticals, Inc. (a) | 5,171 | 1,007,052 | |
Revance Therapeutics, Inc. (a) | 2,040 | 47,165 | |
Supernus Pharmaceuticals, Inc. (a) | 8,478 | 152,519 | |
Theravance Biopharma, Inc. (a) | 2,861 | 69,665 | |
Zogenix, Inc. (a) | 3,818 | 95,755 | |
8,155,480 | |||
TOTAL HEALTH CARE | 105,132,029 | ||
INDUSTRIALS - 17.1% | |||
Aerospace & Defense - 2.1% | |||
AAR Corp. | 79,072 | 2,731,938 | |
Aerojet Rocketdyne Holdings, Inc. (a) | 2,375 | 117,040 | |
Astronics Corp. (a) | 34,663 | 702,619 | |
Axon Enterprise, Inc. (a) | 10,992 | 850,451 | |
Moog, Inc. Class A | 42,268 | 3,259,708 | |
Parsons Corp. | 76,997 | 3,009,813 | |
10,671,569 | |||
Airlines - 0.0% | |||
Mesa Air Group, Inc. (a) | 8,292 | 47,845 | |
Building Products - 1.9% | |||
Advanced Drain Systems, Inc. | 24,670 | 1,032,686 | |
Builders FirstSource, Inc. (a) | 6,795 | 154,314 | |
Gibraltar Industries, Inc. (a) | 11,062 | 560,512 | |
Griffon Corp. | 3,519 | 61,231 | |
Quanex Building Products Corp. | 70,656 | 1,187,021 | |
Simpson Manufacturing Co. Ltd. | 11,132 | 884,215 | |
Trex Co., Inc. (a)(b) | 26,989 | 2,581,498 | |
Universal Forest Products, Inc. | 65,704 | 3,078,889 | |
9,540,366 | |||
Commercial Services & Supplies - 3.7% | |||
ADS Waste Holdings, Inc. (a) | 2,401 | 79,377 | |
Brady Corp. Class A | 45,573 | 2,157,426 | |
Deluxe Corp. | 75,707 | 2,521,043 | |
Herman Miller, Inc. | 82,948 | 2,840,140 | |
Kimball International, Inc. Class B | 160,140 | 2,591,065 | |
Knoll, Inc. | 41,868 | 738,552 | |
Mobile Mini, Inc. | 11,109 | 433,140 | |
Steelcase, Inc. Class A | 175,882 | 2,852,806 | |
Tetra Tech, Inc. | 16,198 | 1,309,932 | |
UniFirst Corp. | 18,806 | 3,494,343 | |
VSE Corp. | 3,200 | 94,240 | |
19,112,064 | |||
Construction & Engineering - 1.0% | |||
Comfort Systems U.S.A., Inc. | 5,408 | 228,326 | |
EMCOR Group, Inc. | 50,482 | 3,883,075 | |
Great Lakes Dredge & Dock Corp. (a) | 92,404 | 896,319 | |
Primoris Services Corp. | 15,428 | 292,823 | |
5,300,543 | |||
Electrical Equipment - 3.3% | |||
Atkore International Group, Inc. (a) | 88,229 | 3,256,532 | |
AZZ, Inc. | 38,050 | 1,403,665 | |
Encore Wire Corp. | 57,110 | 2,796,677 | |
EnerSys | 50,369 | 3,101,723 | |
Generac Holdings, Inc. (a)(b) | 39,062 | 4,022,995 | |
Powell Industries, Inc. | 59,019 | 1,973,005 | |
Preformed Line Products Co. | 12,153 | 593,066 | |
Thermon Group Holdings, Inc. (a) | 2,795 | 49,108 | |
17,196,771 | |||
Machinery - 1.1% | |||
Columbus McKinnon Corp. (NY Shares) | 4,611 | 143,356 | |
Evoqua Water Technologies Corp. (a) | 41,749 | 875,477 | |
Federal Signal Corp. | 3,100 | 89,900 | |
Gorman-Rupp Co. | 7,107 | 227,353 | |
Hillenbrand, Inc. | 41,131 | 962,465 | |
Hurco Companies, Inc. | 20,572 | 579,719 | |
L.B. Foster Co. Class A (a) | 4,187 | 65,987 | |
Mueller Industries, Inc. | 18,451 | 516,259 | |
Park-Ohio Holdings Corp. | 13,970 | 342,544 | |
Rexnord Corp. | 50,798 | 1,481,270 | |
Wabash National Corp. | 4,307 | 47,291 | |
Watts Water Technologies, Inc. Class A | 3,310 | 310,842 | |
5,642,463 | |||
Marine - 0.1% | |||
Costamare, Inc. (b) | 58,579 | 382,521 | |
Professional Services - 2.1% | |||
Barrett Business Services, Inc. | 17,026 | 1,019,857 | |
CRA International, Inc. | 5,390 | 250,689 | |
Heidrick & Struggles International, Inc. | 75,563 | 1,685,055 | |
Kforce, Inc. | 84,590 | 2,576,611 | |
Korn Ferry | 32,756 | 1,145,805 | |
Resources Connection, Inc. | 180,427 | 2,260,750 | |
TriNet Group, Inc. (a) | 39,415 | 2,083,477 | |
11,022,244 | |||
Road & Rail - 0.4% | |||
ArcBest Corp. | 18,526 | 367,000 | |
Heartland Express, Inc. | 22,251 | 398,515 | |
Marten Transport Ltd. | 57,941 | 1,132,167 | |
Universal Logistics Holdings, Inc. | 281 | 4,330 | |
1,902,012 | |||
Trading Companies & Distributors - 1.4% | |||
Applied Industrial Technologies, Inc. | 30,438 | 1,795,538 | |
BMC Stock Holdings, Inc. (a) | 15,362 | 376,830 | |
GATX Corp. | 1,248 | 89,269 | |
GMS, Inc. (a) | 29,376 | 671,242 | |
Herc Holdings, Inc. (a) | 10,364 | 380,152 | |
Lawson Products, Inc. (a) | 1,581 | 63,240 | |
Rush Enterprises, Inc. Class A | 74,013 | 3,102,625 | |
Systemax, Inc. | 41,988 | 875,870 | |
7,354,766 | |||
TOTAL INDUSTRIALS | 88,173,164 | ||
INFORMATION TECHNOLOGY - 14.4% | |||
Communications Equipment - 0.6% | |||
Acacia Communications, Inc. (a) | 2,005 | 137,363 | |
Calix Networks, Inc. (a) | 235,218 | 2,116,962 | |
Comtech Telecommunications Corp. | 4,872 | 136,513 | |
Digi International, Inc. (a) | 22,469 | 297,490 | |
Extreme Networks, Inc. (a) | 44,207 | 222,361 | |
Tessco Technologies, Inc. | 2,417 | 14,478 | |
2,925,167 | |||
Electronic Equipment & Components - 2.4% | |||
Anixter International, Inc. (a) | 2,105 | 205,259 | |
Badger Meter, Inc. (b) | 25,772 | 1,551,732 | |
Belden, Inc. | 22,357 | 892,715 | |
ePlus, Inc. (a) | 8,604 | 651,839 | |
Insight Enterprises, Inc. (a) | 51,114 | 2,815,870 | |
Itron, Inc. (a) | 1,212 | 91,918 | |
Kimball Electronics, Inc. (a) | 63,245 | 856,970 | |
Methode Electronics, Inc. Class A | 33,403 | 1,024,136 | |
PC Connection, Inc. | 46,410 | 1,887,495 | |
Sanmina Corp. (a) | 20,763 | 545,859 | |
ScanSource, Inc. (a) | 41,577 | 1,182,034 | |
Tech Data Corp. (a) | 5,787 | 824,011 | |
12,529,838 | |||
IT Services - 1.4% | |||
CSG Systems International, Inc. | 7,378 | 326,477 | |
EVERTEC, Inc. | 97,267 | 2,886,885 | |
ManTech International Corp. Class A | 8,816 | 660,318 | |
Perspecta, Inc. | 62,781 | 1,567,642 | |
Sykes Enterprises, Inc. (a) | 62,554 | 1,981,711 | |
Verra Mobility Corp. (a) | 1,105 | 16,735 | |
7,439,768 | |||
Semiconductors & Semiconductor Equipment - 5.4% | |||
Alpha & Omega Semiconductor Ltd. (a) | 869 | 9,420 | |
Ambarella, Inc. (a) | 29,838 | 1,773,869 | |
Amkor Technology, Inc. (a) | 269,327 | 2,810,427 | |
Cirrus Logic, Inc. (a) | 54,285 | 3,726,122 | |
Diodes, Inc. (a) | 40,588 | 1,786,278 | |
Enphase Energy, Inc. (a) | 4,327 | 211,893 | |
FormFactor, Inc. (a) | 32,223 | 720,829 | |
Inphi Corp. (a) | 19,513 | 1,456,841 | |
Lattice Semiconductor Corp. (a) | 180,773 | 3,244,875 | |
NeoPhotonics Corp. (a) | 370,767 | 2,450,770 | |
Photronics, Inc. (a) | 13,870 | 172,682 | |
Power Integrations, Inc. | 25,100 | 2,184,955 | |
Rambus, Inc. (a) | 12,645 | 176,777 | |
Silicon Laboratories, Inc. (a) | 38,547 | 3,418,348 | |
Synaptics, Inc. (a) | 47,247 | 3,120,664 | |
Ultra Clean Holdings, Inc. (a) | 14,171 | 296,316 | |
Veeco Instruments, Inc. (a) | 14,968 | 200,422 | |
27,761,488 | |||
Software - 4.3% | |||
Agilysys, Inc. (a) | 93,176 | 2,993,745 | |
AppFolio, Inc. (a) | 6,705 | 824,514 | |
BlackLine, Inc. (a)(b) | 32,296 | 2,020,761 | |
Box, Inc. Class A (a) | 225,739 | 3,781,128 | |
CommVault Systems, Inc. (a) | 62,823 | 2,619,719 | |
Cornerstone OnDemand, Inc. (a) | 36,813 | 1,510,437 | |
MobileIron, Inc. (a) | 286,662 | 1,160,981 | |
Progress Software Corp. | 81,186 | 3,027,426 | |
Q2 Holdings, Inc. (a) | 29,753 | 2,242,484 | |
Rimini Street, Inc. (a) | 972 | 4,491 | |
SPS Commerce, Inc. (a) | 27,243 | 1,432,982 | |
Tenable Holdings, Inc. (a) | 9,342 | 229,066 | |
Verint Systems, Inc. (a) | 5,292 | 290,425 | |
22,138,159 | |||
Technology Hardware, Storage & Peripherals - 0.3% | |||
Astro-Med, Inc. | 1,679 | 18,234 | |
Avid Technology, Inc. (a) | 186,286 | 1,376,654 | |
Diebold Nixdorf, Inc. (a)(b) | 28,472 | 199,873 | |
1,594,761 | |||
TOTAL INFORMATION TECHNOLOGY | 74,389,181 | ||
MATERIALS - 4.2% | |||
Chemicals - 1.1% | |||
FutureFuel Corp. | 85,219 | 866,677 | |
Hawkins, Inc. | 1,345 | 48,084 | |
Koppers Holdings, Inc. (a) | 11,248 | 245,881 | |
Orion Engineered Carbons SA (b) | 16,654 | 236,653 | |
PolyOne Corp. | 45,567 | 1,128,239 | |
Stepan Co. | 32,041 | 2,814,161 | |
Tredegar Corp. | 3,403 | 58,055 | |
Tronox Holdings PLC | 62,201 | 456,555 | |
5,854,305 | |||
Construction Materials - 0.6% | |||
Forterra, Inc. (a) | 209,290 | 2,833,787 | |
Containers & Packaging - 0.4% | |||
Myers Industries, Inc. | 167,033 | 2,266,638 | |
Metals & Mining - 1.4% | |||
Commercial Metals Co. | 94,675 | 1,728,766 | |
Gold Resource Corp. | 17,091 | 68,706 | |
Hecla Mining Co. | 132,618 | 350,112 | |
Materion Corp. | 29,340 | 1,330,276 | |
Novagold Resources, Inc. (a) | 39,356 | 312,268 | |
Ryerson Holding Corp. (a) | 4,250 | 35,403 | |
Schnitzer Steel Industries, Inc. Class A (b) | 20,376 | 335,796 | |
Worthington Industries, Inc. | 87,930 | 2,796,174 | |
6,957,501 | |||
Paper & Forest Products - 0.7% | |||
Boise Cascade Co. | 59,909 | 2,125,571 | |
Louisiana-Pacific Corp. | 4,002 | 113,857 | |
Schweitzer-Mauduit International, Inc. | 44,358 | 1,495,752 | |
3,735,180 | |||
TOTAL MATERIALS | 21,647,411 | ||
REAL ESTATE - 6.4% | |||
Equity Real Estate Investment Trusts (REITs) - 4.8% | |||
Agree Realty Corp. | 3,765 | 270,402 | |
American Assets Trust, Inc. | 78,721 | 3,262,985 | |
Braemar Hotels & Resorts, Inc. | 9,239 | 67,999 | |
Clipper Realty, Inc. | 2,333 | 26,293 | |
CoreCivic, Inc. | 185,422 | 2,746,100 | |
CorePoint Lodging, Inc. | 3,509 | 27,932 | |
DiamondRock Hospitality Co. | 139,044 | 1,268,081 | |
EastGroup Properties, Inc. | 12,949 | 1,628,078 | |
Essential Properties Realty Trust, Inc. | 27,978 | 640,976 | |
Franklin Street Properties Corp. | 7,870 | 56,113 | |
Healthcare Realty Trust, Inc. | 10,214 | 350,340 | |
Kite Realty Group Trust | 36,025 | 581,804 | |
National Storage Affiliates Trust | 23,617 | 796,838 | |
New Senior Investment Group, Inc. | 47,071 | 285,721 | |
Piedmont Office Realty Trust, Inc. Class A | 12,683 | 273,826 | |
PS Business Parks, Inc. | 23,509 | 3,492,262 | |
Rexford Industrial Realty, Inc. | 7,100 | 332,067 | |
RLJ Lodging Trust | 90,323 | 1,193,167 | |
Senior Housing Properties Trust (SBI) | 270,509 | 1,701,502 | |
Sunstone Hotel Investors, Inc. | 253,295 | 2,773,580 | |
The GEO Group, Inc. | 90,620 | 1,326,677 | |
Xenia Hotels & Resorts, Inc. | 120,809 | 1,807,303 | |
24,910,046 | |||
Real Estate Management & Development - 1.6% | |||
Gyrodyne LLC (a) | 346 | 6,408 | |
Kennedy-Wilson Holdings, Inc. | 61,249 | 1,237,842 | |
Marcus & Millichap, Inc. (a) | 46,702 | 1,492,596 | |
Maui Land & Pineapple, Inc. (a) | 2,892 | 31,841 | |
Newmark Group, Inc. | 283,293 | 2,705,448 | |
RE/MAX Holdings, Inc. | 18,223 | 531,200 | |
The RMR Group, Inc. | 55,316 | 2,061,074 | |
8,066,409 | |||
TOTAL REAL ESTATE | 32,976,455 | ||
UTILITIES - 2.9% | |||
Electric Utilities - 1.6% | |||
Allete, Inc. | 32,150 | 2,218,029 | |
El Paso Electric Co. | 2,736 | 185,692 | |
MGE Energy, Inc. | 2,631 | 187,696 | |
Otter Tail Corp. | 26,761 | 1,300,852 | |
PNM Resources, Inc. (b) | 6,343 | 298,628 | |
Portland General Electric Co. | 73,842 | 4,017,743 | |
Spark Energy, Inc. Class A, | 15,870 | 135,847 | |
8,344,487 | |||
Gas Utilities - 0.2% | |||
New Jersey Resources Corp. | 18,100 | 639,111 | |
South Jersey Industries, Inc. | 9,096 | 246,047 | |
Southwest Gas Holdings, Inc. (b) | 1,105 | 71,471 | |
956,629 | |||
Independent Power and Renewable Electricity Producers - 0.7% | |||
Atlantic Power Corp. (a) | 97,440 | 221,189 | |
Clearway Energy, Inc. Class A | 146,233 | 2,967,068 | |
Ormat Technologies, Inc. | 535 | 37,279 | |
Pattern Energy Group, Inc. | 2,736 | 74,009 | |
Sunnova Energy International, Inc. | 1,986 | 34,358 | |
3,333,903 | |||
Multi-Utilities - 0.1% | |||
Avista Corp. | 2,800 | 132,020 | |
Black Hills Corp. | 6,615 | 477,603 | |
NorthWestern Energy Corp. | 1,738 | 122,251 | |
731,874 | |||
Water Utilities - 0.3% | |||
American States Water Co. | 10,729 | 821,734 | |
Artesian Resources Corp. Class A | 732 | 25,130 | |
Consolidated Water Co., Inc. | 10,280 | 166,125 | |
SJW Corp. (b) | 2,485 | 152,032 | |
York Water Co. | 5,734 | 242,491 | |
1,407,512 | |||
TOTAL UTILITIES | 14,774,405 | ||
TOTAL COMMON STOCKS | |||
(Cost $493,248,659) | 509,291,003 | ||
Principal Amount | Value | ||
U.S. Treasury Obligations - 0.0% | |||
U.S. Treasury Bills, yield at date of purchase 1.64% 3/19/20 (d) | |||
(Cost $249,796) | 250,000 | 249,830 | |
Shares | Value | ||
Money Market Funds - 7.4% | |||
Fidelity Cash Central Fund 1.60% (e) | 4,943,265 | $4,944,253 | |
Fidelity Securities Lending Cash Central Fund 1.60% (e)(f) | 33,035,190 | 33,038,493 | |
TOTAL MONEY MARKET FUNDS | |||
(Cost $37,980,009) | 37,982,746 | ||
TOTAL INVESTMENT IN SECURITIES - 106.1% | |||
(Cost $531,478,464) | 547,523,579 | ||
NET OTHER ASSETS (LIABILITIES) - (6.1)% | (31,563,080) | ||
NET ASSETS - 100% | $515,960,499 |
Futures Contracts | |||||
Number of contracts | Expiration Date | Notional Amount | Value | Unrealized Appreciation/(Depreciation) | |
Purchased | |||||
Equity Index Contracts | |||||
CME E-mini Russell 2000 Index Contracts (United States) | 74 | March 2020 | $5,457,130 | $(381,923) | $(381,923) |
The notional amount of futures purchased as a percentage of Net Assets is 1.1%
Legend
(a) Non-income producing
(b) Security or a portion of the security is on loan at period end.
(c) Level 3 security
(d) Security or a portion of the security was pledged to cover margin requirements for futures contracts. At period end, the value of securities pledged amounted to $249,830.
(e) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements, which are not covered by the Fund's Report of Independent Registered Public Accounting Firm, are available on the SEC's website or upon request.
(f) Investment made with cash collateral received from securities on loan.
Affiliated Central Funds
Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:
Fund | Income earned |
Fidelity Cash Central Fund | $132,671 |
Fidelity Securities Lending Cash Central Fund | 486,675 |
Total | $619,346 |
Amounts in the income column in the above table include any capital gain distributions from underlying funds, which are presented in the corresponding line-item in the Statement of Operations, if applicable. Amount for Fidelity Securities Lending Cash Central Fund represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities.
Investment Valuation
The following is a summary of the inputs used, as of February 29, 2020, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. For more information on valuation inputs, and their aggregation into the levels used below, please refer to the Investment Valuation section in the accompanying Notes to Financial Statements.
Valuation Inputs at Reporting Date: | ||||
Description | Total | Level 1 | Level 2 | Level 3 |
Investments in Securities: | ||||
Equities: | ||||
Communication Services | $12,494,749 | $12,494,749 | $-- | $-- |
Consumer Discretionary | 52,323,898 | 52,323,898 | -- | -- |
Consumer Staples | 12,675,372 | 12,675,372 | -- | -- |
Energy | 4,851,315 | 4,851,315 | -- | -- |
Financials | 89,853,024 | 89,853,024 | -- | -- |
Health Care | 105,132,029 | 105,132,029 | -- | 0 |
Industrials | 88,173,164 | 88,173,164 | -- | -- |
Information Technology | 74,389,181 | 74,389,181 | -- | -- |
Materials | 21,647,411 | 21,647,411 | -- | -- |
Real Estate | 32,976,455 | 32,976,455 | -- | -- |
Utilities | 14,774,405 | 14,774,405 | -- | -- |
U.S. Government and Government Agency Obligations | 249,830 | -- | 249,830 | -- |
Money Market Funds | 37,982,746 | 37,982,746 | -- | -- |
Total Investments in Securities: | $547,523,579 | $547,273,749 | $249,830 | $0 |
Derivative Instruments: | ||||
Liabilities | ||||
Futures Contracts | $(381,923) | $(381,923) | $-- | $-- |
Total Liabilities | $(381,923) | $(381,923) | $-- | $-- |
Total Derivative Instruments: | $(381,923) | $(381,923) | $-- | $-- |
Value of Derivative Instruments
The following table is a summary of the Fund's value of derivative instruments by primary risk exposure as of February 29, 2020. For additional information on derivative instruments, please refer to the Derivative Instruments section in the accompanying Notes to Financial Statements.
Primary Risk Exposure / Derivative Type | Value | |
Asset | Liability | |
Equity Risk | ||
Futures Contracts(a) | $0 | $(381,923) |
Total Equity Risk | 0 | (381,923) |
Total Value of Derivatives | $0 | $(381,923) |
(a) Reflects gross cumulative appreciation (depreciation) on futures contracts as presented in the Schedule of Investments. In the Statement of Assets and Liabilities, the period end daily variation margin is included in receivable or payable for daily variation margin on futures contracts, and the net cumulative appreciation (depreciation) is included in Total accumulated earnings (loss).
See accompanying notes which are an integral part of the financial statements.
Financial Statements
Statement of Assets and Liabilities
February 29, 2020 | ||
Assets | ||
Investment in securities, at value (including securities loaned of $32,051,201) See accompanying schedule:
Unaffiliated issuers (cost $493,498,455) |
$509,540,833 | |
Fidelity Central Funds (cost $37,980,009) | 37,982,746 | |
Total Investment in Securities (cost $531,478,464) | $547,523,579 | |
Receivable for investments sold | 6,982,852 | |
Receivable for fund shares sold | 852,150 | |
Dividends receivable | 505,770 | |
Distributions receivable from Fidelity Central Funds | 24,798 | |
Total assets | 555,889,149 | |
Liabilities | ||
Payable to custodian bank | $105,952 | |
Payable for investments purchased | $3,734,858 | |
Payable for fund shares redeemed | 2,702,930 | |
Accrued management fee | 314,442 | |
Payable for daily variation margin on futures contracts | 39,261 | |
Collateral on securities loaned | 33,031,207 | |
Total liabilities | 39,928,650 | |
Net Assets | $515,960,499 | |
Net Assets consist of: | ||
Paid in capital | $517,896,458 | |
Total accumulated earnings (loss) | (1,935,959) | |
Net Assets | $515,960,499 | |
Net Asset Value, offering price and redemption price per share ($515,960,499 ÷ 45,612,145 shares) | $11.31 |
See accompanying notes which are an integral part of the financial statements.
Statement of Operations
Year ended February 29, 2020 | ||
Investment Income | ||
Dividends | $9,360,707 | |
Interest | 8,767 | |
Income from Fidelity Central Funds (including $486,675 from security lending) | 619,346 | |
Total income | 9,988,820 | |
Expenses | ||
Management fee | $4,031,811 | |
Independent trustees' fees and expenses | 3,490 | |
Commitment fees | 1,642 | |
Total expenses before reductions | 4,036,943 | |
Expense reductions | (941) | |
Total expenses after reductions | 4,036,002 | |
Net investment income (loss) | 5,952,818 | |
Realized and Unrealized Gain (Loss) | ||
Net realized gain (loss) on: | ||
Investment securities: | ||
Unaffiliated issuers | (303,169) | |
Fidelity Central Funds | 1,601 | |
Futures contracts | 78,641 | |
Total net realized gain (loss) | (222,927) | |
Change in net unrealized appreciation (depreciation) on: | ||
Investment securities: | ||
Unaffiliated issuers | (57,816,872) | |
Fidelity Central Funds | (17) | |
Futures contracts | (1,181,352) | |
Total change in net unrealized appreciation (depreciation) | (58,998,241) | |
Net gain (loss) | (59,221,168) | |
Net increase (decrease) in net assets resulting from operations | $(53,268,350) |
See accompanying notes which are an integral part of the financial statements.
Statement of Changes in Net Assets
Year ended February 29, 2020 | Year ended February 28, 2019 | |
Increase (Decrease) in Net Assets | ||
Operations | ||
Net investment income (loss) | $5,952,818 | $6,340,564 |
Net realized gain (loss) | (222,927) | 54,781,226 |
Change in net unrealized appreciation (depreciation) | (58,998,241) | (36,147,809) |
Net increase (decrease) in net assets resulting from operations | (53,268,350) | 24,973,981 |
Distributions to shareholders | (5,905,233) | (88,826,591) |
Share transactions | ||
Proceeds from sales of shares | 51,342,519 | 106,108,501 |
Reinvestment of distributions | 5,607,999 | 84,289,442 |
Cost of shares redeemed | (182,987,536) | (188,185,526) |
Net increase (decrease) in net assets resulting from share transactions | (126,037,018) | 2,212,417 |
Total increase (decrease) in net assets | (185,210,601) | (61,640,193) |
Net Assets | ||
Beginning of period | 701,171,100 | 762,811,293 |
End of period | $515,960,499 | $701,171,100 |
Other Information | ||
Shares | ||
Sold | 4,135,743 | 7,748,555 |
Issued in reinvestment of distributions | 426,140 | 7,097,889 |
Redeemed | (14,743,945) | (14,298,545) |
Net increase (decrease) | (10,182,062) | 547,899 |
See accompanying notes which are an integral part of the financial statements.
Financial Highlights
Fidelity Small Cap Enhanced Index Fund
Years ended February 28, | 2020 A | 2019 | 2018 | 2017 | 2016 A |
Selected PerShare Data | |||||
Net asset value, beginning of period | $12.57 | $13.81 | $14.32 | $10.99 | $13.05 |
Income from Investment Operations | |||||
Net investment income (loss)B | .12 | .11 | .13 | .12 | .11 |
Net realized and unrealized gain (loss) | (1.26) | .31 | .55 | 3.31 | (1.52) |
Total from investment operations | (1.14) | .42 | .68 | 3.43 | (1.41) |
Distributions from net investment income | (.12) | (.12) | (.13) | (.10) | (.09) |
Distributions from net realized gain | | (1.54) | (1.06) | | (.56) |
Total distributions | (.12) | (1.66) | (1.19) | (.10) | (.65) |
Redemption fees added to paid in capitalB | | | | C | C |
Net asset value, end of period | $11.31 | $12.57 | $13.81 | $14.32 | $10.99 |
Total ReturnD | (9.18)% | 4.01% | 4.95% | 31.15% | (11.20)% |
Ratios to Average Net AssetsE,F | |||||
Expenses before reductions | .64% | .64% | .64% | .67% | .67% |
Expenses net of fee waivers, if any | .64% | .64% | .64% | .67% | .67% |
Expenses net of all reductions | .64% | .64% | .64% | .67% | .67% |
Net investment income (loss) | .94% | .84% | .89% | .93% | .90% |
Supplemental Data | |||||
Net assets, end of period (000 omitted) | $515,960 | $701,171 | $762,811 | $1,210,189 | $529,009 |
Portfolio turnover rateG | 79% | 88% | 100% | 76% | 87% |
A For the year ended February 29.
B Calculated based on average shares outstanding during the period.
C Amount represents less than $.005 per share.
D Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.
E Fees and expenses of any underlying Fidelity Central Funds are not included in the Fund's expense ratio. The Fund indirectly bears its proportionate share of the expenses of any underlying Fidelity Central Funds.
F Expense ratios reflect operating expenses of the Fund. Expenses before reductions do not reflect amounts reimbursed by the investment adviser or reductions from expense offset arrangements and do not represent the amount paid by the Fund during periods when reimbursements or reductions occur. Expenses net of fee waivers reflect expenses after reimbursement by the investment adviser but prior to reductions from expense offset arrangements. Expenses net of all reductions represent the net expenses paid by the Fund.
G Amount does not include the portfolio activity of any underlying Fidelity Central Funds.
See accompanying notes which are an integral part of the financial statements.
Notes to Financial Statements
For the period ended February 29, 2020
1. Organization.
Fidelity Small Cap Enhanced Index Fund (the Fund) is a fund of Fidelity Commonwealth Trust II (the Trust) and is authorized to issue an unlimited number of shares. Share transactions on the Statement of Changes in Net Assets may contain exchanges between affiliated funds. The Trust is registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company organized as a Delaware statutory trust.
Effective January 1, 2020:
Investment advisers Fidelity Investments Money Management, Inc., FMR Co., Inc., and Fidelity SelectCo, LLC, merged with and into Fidelity Management & Research Company. In connection with the merger transactions, the resulting, merged investment adviser was then redomiciled from Massachusetts to Delaware, changed its corporate structure from a corporation to a limited liability company, and changed its name to "Fidelity Management & Research Company LLC".
2. Significant Accounting Policies.
The Fund is an investment company and applies the accounting and reporting guidance of the Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 946 Financial Services Investments Companies. The financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP), which require management to make certain estimates and assumptions at the date of the financial statements. Actual results could differ from those estimates. Subsequent events, if any, through the date that the financial statements were issued have been evaluated in the preparation of the financial statements. The following summarizes the significant accounting policies of the Fund:
Investment Valuation. Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events, changes in interest rates and credit quality. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund's valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee.
The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels as shown below:
Valuation techniques used to value the Fund's investments by major category are as follows:
Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.
Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing vendors or from brokers who make markets in such securities. U.S. government and government agency obligations are valued by pricing vendors who utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type or by broker-supplied prices. When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing vendors. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.
Futures contracts are valued at the settlement price established each day by the board of trade or exchange on which they are traded and are categorized as Level 1 in the hierarchy. Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy.
Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. The aggregate value of investments by input level as of February 29, 2020 is included at the end of the Fund's Schedule of Investments.
Investment Transactions and Income. For financial reporting purposes, the Fund's investment holdings and NAV include trades executed through the end of the last business day of the period. The NAV per share for processing shareholder transactions is calculated as of the close of business of the New York Stock Exchange (NYSE), normally 4:00 p.m. Eastern time and includes trades executed through the end of the prior business day. Gains and losses on securities sold are determined on the basis of identified cost and include proceeds received from litigation. Dividend income is recorded on the ex-dividend date, except for certain dividends from foreign securities where the ex-dividend date may have passed, which are recorded as soon as the Fund is informed of the ex-dividend date. Non-cash dividends included in dividend income, if any, are recorded at the fair market value of the securities received. Income and capital gain distributions from Fidelity Central Funds, if any, are recorded on the ex-dividend date. Certain distributions received by the Fund represent a return of capital or capital gain. The Fund determines the components of these distributions subsequent to the ex-dividend date, based upon receipt of tax filings or other correspondence relating to the underlying investment. These distributions are recorded as a reduction of cost of investments and/or as a realized gain. Interest income is accrued as earned and includes coupon interest and amortization of premium and accretion of discount on debt securities as applicable.
Expenses. Expenses directly attributable to a fund are charged to that fund. Expenses attributable to more than one fund are allocated among the respective funds on the basis of relative net assets or other appropriate methods. Expense estimates are accrued in the period to which they relate and adjustments are made when actual amounts are known.
Income Tax Information and Distributions to Shareholders. Each year, the Fund intends to qualify as a regulated investment company under Subchapter M of the Internal Revenue Code, including distributing substantially all of its taxable income and realized gains. As a result, no provision for U.S. Federal income taxes is required. As of February 29, 2020, the Fund did not have any unrecognized tax benefits in the financial statements; nor is the Fund aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. The Fund files a U.S. federal tax return, in addition to state and local tax returns as required. The Fund's federal income tax returns are subject to examination by the Internal Revenue Service (IRS) for a period of three fiscal years after they are filed. State and local tax returns may be subject to examination for an additional fiscal year depending on the jurisdiction.
Distributions are declared and recorded on the ex-dividend date. Income and capital gain distributions are determined in accordance with income tax regulations, which may differ from GAAP.
Capital accounts within the financial statements are adjusted for permanent book-tax differences. These adjustments have no impact on net assets or the results of operations. Capital accounts are not adjusted for temporary book-tax differences which will reverse in a subsequent period.
Book-tax differences are primarily due to futures contracts, passive foreign investment companies (PFIC), market discount, partnerships (including allocations from Fidelity Central Funds), wash sales and excise tax regulations.
As of period end, the cost and unrealized appreciation (depreciation) in securities, and derivatives if applicable, for federal income tax purposes were as follows:
Gross unrealized appreciation | $70,788,631 |
Gross unrealized depreciation | (56,754,674) |
Net unrealized appreciation (depreciation) | $14,033,957 |
Tax Cost | $533,489,622 |
The tax-based components of distributable earnings as of period end were as follows:
Capital loss carryforward | $(15,755,779) |
Net unrealized appreciation (depreciation) on securities and other investments | $14,033,957 |
Capital loss carryforwards are only available to offset future capital gains of the Fund to the extent provided by regulations and may be limited. The capital loss carryforward information presented below, including any applicable limitation, is estimated as of fiscal period end and is subject to adjustment.
No expiration | |
Short-term | $(15,755,779) |
The fund intends to elect to defer to its next fiscal year $214,137 of ordinary losses recognized during the period January 1, 2020 to February 29, 2020.
The tax character of distributions paid was as follows:
February 29, 2020 | February 28, 2019 | |
Ordinary Income | $5,905,233 | $ 9,620,987 |
Long-term Capital Gains | | 79,205,604 |
Total | $5,905,233 | $ 88,826,591 |
3. Derivative Instruments.
Risk Exposures and the Use of Derivative Instruments. The Fund's investment objective allows the Fund to enter into various types of derivative contracts, including futures contracts. Derivatives are investments whose value is primarily derived from underlying assets, indices or reference rates and may be transacted on an exchange or over-the-counter (OTC). Derivatives may involve a future commitment to buy or sell a specified asset based on specified terms, to exchange future cash flows at periodic intervals based on a notional principal amount, or for one party to make one or more payments upon the occurrence of specified events in exchange for periodic payments from the other party.
The Fund used derivatives to increase returns and to manage exposure to certain risks as defined below. The success of any strategy involving derivatives depends on analysis of numerous economic factors, and if the strategies for investment do not work as intended, the Fund may not achieve its objectives.
The Fund's use of derivatives increased or decreased its exposure to the following risk:
Equity Risk |
Equity risk relates to the fluctuations in the value of financial instruments as a result of changes in market prices (other than those arising from interest rate risk or foreign exchange risk), whether caused by factors specific to an individual investment, its issuer, or all factors affecting all instruments traded in a market or market segment.
|
The Fund is also exposed to additional risks from investing in derivatives, such as liquidity risk and counterparty credit risk. Liquidity risk is the risk that the Fund will be unable to close out the derivative in the open market in a timely manner. Counterparty credit risk is the risk that the counterparty will not be able to fulfill its obligation to the Fund. Counterparty credit risk related to exchange-traded futures contracts may be mitigated by the protection provided by the exchange on which they trade.
Investing in derivatives may involve greater risks than investing in the underlying assets directly and, to varying degrees, may involve risk of loss in excess of any initial investment and collateral received and amounts recognized in the Statement of Assets and Liabilities. In addition, there may be the risk that the change in value of the derivative contract does not correspond to the change in value of the underlying instrument.
Futures Contracts. A futures contract is an agreement between two parties to buy or sell a specified underlying instrument for a fixed price at a specified future date. The Fund used futures contracts to manage its exposure to the stock market.
Upon entering into a futures contract, a fund is required to deposit either cash or securities (initial margin) with a clearing broker in an amount equal to a certain percentage of the face value of the contract. Futures contracts are marked-to-market daily and subsequent daily payments (variation margin) are made or received by a fund depending on the daily fluctuations in the value of the futures contracts and are recorded as unrealized appreciation or (depreciation). This receivable and/or payable, if any, is included in daily variation margin on futures contracts in the Statement of Assets and Liabilities. Realized gain or (loss) is recorded upon the expiration or closing of a futures contract. The net realized gain (loss) and change in net unrealized appreciation (depreciation) on futures contracts during the period is presented in the Statement of Operations.
Any open futures contracts at period end are presented in the Schedule of Investments under the caption "Futures Contracts". The notional amount at value reflects each contract's exposure to the underlying instrument or index at period end and is representative of volume of activity during the period. Securities deposited to meet initial margin requirements are identified in the Schedule of Investments.
4. Purchases and Sales of Investments.
Purchases and sales of securities, other than short-term securities are noted in the table below.
Purchases ($) | Sales ($) | |
Fidelity Small Cap Enhanced Index Fund | 490,986,499 | 611,024,794 |
5. Fees and Other Transactions with Affiliates.
Management Fee. Fidelity Management & Research Company LLC (the investment adviser) and its affiliates provide the Fund with investment management related services for which the Fund pays a monthly management fee. The Fund pays an all-inclusive management fee based on annual rate of .64% of the Fund's average net assets; and the investment adviser pays all ordinary operating expenses of the Fund, except fees and expenses of the independent Trustees and certain miscellaneous expenses such as proxy and shareholder meeting expenses. The management fee is reduced by an amount equal to the fees and expenses paid by the Fund to the independent Trustees.
Sub-Adviser. Geode Capital Management, LLC (Geode), serves as sub-adviser for the Funds. Geode provides discretionary investment advisory services to the Funds and is paid by the investment adviser for providing these services.
Interfund Trades. Funds may purchase from or sell securities to other Fidelity Funds under procedures adopted by the Board. The procedures have been designed to ensure these interfund trades are executed in accordance with Rule 17a-7 of the 1940 Act. Interfund trades are included within the respective purchases and sales amounts shown in the Purchases and Sales of Investments note.
6. Investments in Fidelity Central Funds.
The Fund invests in Fidelity Central Funds, which are open-end investment companies available only to other investment companies and accounts managed by the investment adviser and its affiliates. The Fund's Schedule of Investments lists each of the Fidelity Central Funds held as of period end, if any, as an investment of the Fund, but does not include the underlying holdings of each Fidelity Central Fund. As an Investing Fund, the Fund indirectly bears its proportionate share of the expenses of the underlying Fidelity Central Funds.
The Fidelity Money Market Central Funds are managed by FMR. Annualized expenses of the Money Market Central Funds as of their most recent shareholder report date ranged from less than .005% to .01%.
A complete unaudited list of holdings for each Fidelity Central Fund is available upon request or at the Securities and Exchange Commission (the SEC) website at www.sec.gov. In addition, the financial statements of the Fidelity Central Funds, which are not covered by the Fund's Report of Independent Registered Public Accounting Firm, are available on the SEC website or upon request.
7. Committed Line of Credit.
Certain Funds participate with other funds managed by the investment adviser or an affiliate in a $4.25 billion credit facility (the "line of credit") to be utilized for temporary or emergency purposes to fund shareholder redemptions or for other short-term liquidity purposes. The participating funds have agreed to pay commitment fees on their pro-rata portion of the line of credit, which are reflected in Commitment fees on the Statement of Operations, and are as follows:
Amount | |
Fidelity Small Cap Enhanced Index Fund | $1,642 |
During the period, there were no borrowings on this line of credit.
8. Security Lending.
The Fund lends portfolio securities from time to time in order to earn additional income. For equity securities, lending agents are used, including National Financial Services (NFS), an affiliate of the Fund. Pursuant to a securities lending agreement, NFS will receive a fee, which is capped at 9.9% of daily lending revenue, for its services as lending agent. The Fund may lend securities to certain qualified borrowers, including NFS. On the settlement date of the loan, the Fund receives collateral (in the form of U.S. Treasury obligations, letters of credit and/or cash) against the loaned securities and maintains collateral in an amount not less than 100% of the market value of the loaned securities during the period of the loan. The market value of the loaned securities is determined at the close of business of the Fund and any additional required collateral is delivered to the Fund on the next business day. The Fund or borrower may terminate the loan at any time, and if the borrower defaults on its obligation to return the securities loaned because of insolvency or other reasons, the Fund may apply collateral received from the borrower against the obligation. The Fund may experience delays and costs in recovering the securities loaned. Any cash collateral received is maintained at the Fund's custodian and/or invested in the Fidelity Securities Lending Cash Central Fund. The value of loaned securities and cash collateral at period end are disclosed on the Fund's Statement of Assets and Liabilities. The value of securities loaned to NFS, as affiliated borrower, at period end was $208,026. Total fees paid by the Fund to NFS, as lending agent, amounted to $41,015. Security lending income represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities. Security lending income is presented in the Statement of Operations as a component of income from Fidelity Central Funds, and includes $24,457 from securities loaned to NFS, as affiliated borrower.
9. Expense Reductions.
Through arrangements with the Fund's custodian, credits realized as a result of certain uninvested cash balances were used to reduce the Fund's expenses by $941.
10. Other.
The Fund's organizational documents provide former and current trustees and officers with a limited indemnification against liabilities arising in connection with the performance of their duties to the Fund. In the normal course of business, the Fund may also enter into contracts that provide general indemnifications. The Fund's maximum exposure under these arrangements is unknown as this would be dependent on future claims that may be made against the Fund. The risk of material loss from such claims is considered remote.
11. Coronavirus (Covid-19) Pandemic.
An outbreak of COVID-19 first detected in China during December 2019 has since spread globally and was declared a pandemic by the World Health Organization during March 2020. Developments that disrupt global economies and financial markets, such as the COVID-19 pandemic, may magnify factors that affect the Fund's performance.
Report of Independent Registered Public Accounting Firm
To the Board of Trustees of Fidelity Commonwealth Trust II and Shareholders of Fidelity Small Cap Enhanced Index Fund
Opinion on the Financial Statements
We have audited the accompanying statement of assets and liabilities, including the schedule of investments, of Fidelity Small Cap Enhanced Index Fund (one of the funds constituting Fidelity Commonwealth Trust II, referred to hereafter as the Fund) as of February 29, 2020, the related statement of operations for the year ended February 29, 2020, the statement of changes in net assets for each of the two years in the period ended February 29, 2020, including the related notes, and the financial highlights for each of the five years in the period ended February 29, 2020(collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Fund as of February 29, 2020, the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period ended February 29, 2020 and the financial highlights for each of the five years in the period ended February 29, 2020 in conformity with accounting principles generally accepted in the United States of America.
Basis for Opinion
These financial statements are the responsibility of the Funds management. Our responsibility is to express an opinion on the Funds financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Fund in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of February 29, 2020 by correspondence with the custodian and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.
PricewaterhouseCoopers LLP
Boston, Massachusetts
April 9, 2020
We have served as the auditor of one or more investment companies in the Fidelity group of funds since 1932.
Trustees and Officers
The Trustees, Members of the Advisory Board (if any), and officers of the trusts for central funds housed in an LLC: fund, as applicable, are listed below. The Board of Trustees governs the fund and is responsible for protecting the interests of shareholders. The Trustees are experienced executives who meet periodically throughout the year to oversee the fund's activities, review contractual arrangements with companies that provide services to the fund, oversee management of the risks associated with such activities and contractual arrangements, and review the fund's performance. Except for Michael E. Wiley, each of the Trustees oversees 302 funds. Michael E. Wiley, oversees 199 funds.
The Trustees hold office without limit in time except that (a) any Trustee may resign; (b) any Trustee may be removed by written instrument, signed by at least two-thirds of the number of Trustees prior to such removal; (c) any Trustee who requests to be retired or who has become incapacitated by illness or injury may be retired by written instrument signed by a majority of the other Trustees; and (d) any Trustee may be removed at any special meeting of shareholders by a two-thirds vote of the outstanding voting securities of the trust. Each Trustee who is not an interested person (as defined in the 1940 Act) of the trust and the fund is referred to herein as an Independent Trustee. Each Independent Trustee shall retire not later than the last day of the calendar year in which his or her 75th birthday occurs. The Independent Trustees may waive this mandatory retirement age policy with respect to individual Trustees. Officers and Advisory Board Members hold office without limit in time, except that any officer or Advisory Board Member may resign or may be removed by a vote of a majority of the Trustees at any regular meeting or any special meeting of the Trustees. Except as indicated, each individual has held the office shown or other offices in the same company for the past five years.
The funds Statement of Additional Information (SAI) includes more information about the Trustees. To request a free copy, call Fidelity at 1-800-544-8544.
Experience, Skills, Attributes, and Qualifications of the Trustees. The Governance and Nominating Committee has adopted a statement of policy that describes the experience, qualifications, attributes, and skills that are necessary and desirable for potential Independent Trustee candidates (Statement of Policy). The Board believes that each Trustee satisfied at the time he or she was initially elected or appointed a Trustee, and continues to satisfy, the standards contemplated by the Statement of Policy. The Governance and Nominating Committee also engages professional search firms to help identify potential Independent Trustee candidates who have the experience, qualifications, attributes, and skills consistent with the Statement of Policy. From time to time, additional criteria based on the composition and skills of the current Independent Trustees, as well as experience or skills that may be appropriate in light of future changes to board composition, business conditions, and regulatory or other developments, have also been considered by the professional search firms and the Governance and Nominating Committee. In addition, the Board takes into account the Trustees' commitment and participation in Board and committee meetings, as well as their leadership of standing and ad hoc committees throughout their tenure.
In determining that a particular Trustee was and continues to be qualified to serve as a Trustee, the Board has considered a variety of criteria, none of which, in isolation, was controlling. The Board believes that, collectively, the Trustees have balanced and diverse experience, qualifications, attributes, and skills, which allow the Board to operate effectively in governing the fund and protecting the interests of shareholders. Information about the specific experience, skills, attributes, and qualifications of each Trustee, which in each case led to the Board's conclusion that the Trustee should serve (or continue to serve) as a trustee of the fund, is provided below.
Board Structure and Oversight Function. James C. Curvey is an interested person and currently serves as Chairman. The Trustees have determined that an interested Chairman is appropriate and benefits shareholders because an interested Chairman has a personal and professional stake in the quality and continuity of services provided to the fund. Independent Trustees exercise their informed business judgment to appoint an individual of their choosing to serve as Chairman, regardless of whether the Trustee happens to be independent or a member of management. The Independent Trustees have determined that they can act independently and effectively without having an Independent Trustee serve as Chairman and that a key structural component for assuring that they are in a position to do so is for the Independent Trustees to constitute a substantial majority for the Board. The Independent Trustees also regularly meet in executive session. Ned C. Lautenbach serves as Chairman of the Independent Trustees and as such (i) acts as a liaison between the Independent Trustees and management with respect to matters important to the Independent Trustees and (ii) with management prepares agendas for Board meetings.
Fidelity® funds are overseen by different Boards of Trustees. The fund's Board oversees Fidelity's high income and certain equity funds, and other Boards oversee Fidelity's investment-grade bond, money market, asset allocation, and other equity funds. The asset allocation funds may invest in Fidelity® funds overseen by the fund's Board. The use of separate Boards, each with its own committee structure, allows the Trustees of each group of Fidelity® funds to focus on the unique issues of the funds they oversee, including common research, investment, and operational issues. On occasion, the separate Boards establish joint committees to address issues of overlapping consequences for the Fidelity® funds overseen by each Board.
The Trustees operate using a system of committees to facilitate the timely and efficient consideration of all matters of importance to the Trustees, the fund, and fund shareholders and to facilitate compliance with legal and regulatory requirements and oversight of the fund's activities and associated risks. The Board, acting through its committees, has charged FMR and its affiliates with (i) identifying events or circumstances the occurrence of which could have demonstrably adverse effects on the fund's business and/or reputation; (ii) implementing processes and controls to lessen the possibility that such events or circumstances occur or to mitigate the effects of such events or circumstances if they do occur; and (iii) creating and maintaining a system designed to evaluate continuously business and market conditions in order to facilitate the identification and implementation processes described in (i) and (ii) above. Because the day-to-day operations and activities of the fund are carried out by or through FMR, its affiliates, and other service providers, the fund's exposure to risks is mitigated but not eliminated by the processes overseen by the Trustees. While each of the Board's committees has responsibility for overseeing different aspects of the fund's activities, oversight is exercised primarily through the Operations, Audit, and Compliance Committees. Appropriate personnel, including but not limited to the fund's Chief Compliance Officer (CCO), FMR's internal auditor, the independent accountants, the fund's Treasurer and portfolio management personnel, make periodic reports to the Board's committees, as appropriate, including an annual review of Fidelity's risk management program for the Fidelity® funds. The responsibilities of each standing committee, including their oversight responsibilities, are described further under "Standing Committees of the Trustees."
Interested Trustees*:
Correspondence intended for a Trustee who is an interested person may be sent to Fidelity Investments, 245 Summer Street, Boston, Massachusetts 02210.
Name, Year of Birth; Principal Occupations and Other Relevant Experience+
James C. Curvey (1935)
Year of Election or Appointment: 2018
Trustee
Chairman of the Board of Trustees
Mr. Curvey also serves as Trustee of other Fidelity® funds. Mr. Curvey is Vice Chairman (2007-present) and Director of FMR LLC (diversified financial services company). In addition, Mr. Curvey is an Overseer Emeritus for the Boston Symphony Orchestra, a Director of Artis-Naples, and a Trustee of Brewster Academy in Wolfeboro, New Hampshire. Previously, Mr. Curvey served as a Director of Fidelity Research & Analysis Co. (investment adviser firm, 2009-2018), Director of Fidelity Investments Money Management, Inc. (investment adviser firm, 2009-2014) and a Director of FMR and FMR Co., Inc. (investment adviser firms, 2007-2014).
* Determined to be an Interested Trustee by virtue of, among other things, his or her affiliation with the trust or various entities under common control with FMR.
+ The information includes the Trustee's principal occupation during the last five years and other information relating to the experience, attributes, and skills relevant to the Trustee's qualifications to serve as a Trustee, which led to the conclusion that the Trustee should serve as a Trustee for the fund.
Independent Trustees:
Correspondence intended for an Independent Trustee may be sent to Fidelity Investments, P.O. Box 55235, Boston, Massachusetts 02205-5235.
Name, Year of Birth; Principal Occupations and Other Relevant Experience+
Dennis J. Dirks (1948)
Year of Election or Appointment: 2018
Trustee
Mr. Dirks also serves as Trustee of other Fidelity® funds. Prior to his retirement in May 2003, Mr. Dirks served as Chief Operating Officer and as a member of the Board of The Depository Trust & Clearing Corporation (financial markets infrastructure), President, Chief Operating Officer and a member of the Board of The Depository Trust Company (DTC), President and a member of the Board of the National Securities Clearing Corporation (NSCC), Chief Executive Officer and a member of the Board of the Government Securities Clearing Corporation and Chief Executive Officer and a member of the Board of the Mortgage-Backed Securities Clearing Corporation. Mr. Dirks currently serves as a member of the Finance Committee (2016-present) and Board (2017-present) and is Treasurer (2018-present) of the Asolo Repertory Theatre.
Donald F. Donahue (1950)
Year of Election or Appointment: 2017
Trustee
Mr. Donahue also serves as Trustee of other Fidelity® funds. Mr. Donahue serves as President and Chief Executive Officer of Miranda Partners, LLC (risk consulting for the financial services industry, 2012-present). Previously, Mr. Donahue served as Chief Executive Officer (2006-2012), Chief Operating Officer (2003-2006) and Managing Director, Customer Marketing and Development (1999-2003) of The Depository Trust & Clearing Corporation (financial markets infrastructure). Mr. Donahue currently serves as a member (2007-present) and Co-Chairman (2016-present) of the Board of United Way of New York, a member of the Board of NYC Leadership Academy (2012-present) and a member of the Board of Advisors of Ripple Labs, Inc. (financial services, 2015-present). Mr. Donahue previously served as a member of the Advisory Board of certain Fidelity® funds (2015-2018).
Alan J. Lacy (1953)
Year of Election or Appointment: 2018
Trustee
Mr. Lacy also serves as Trustee of other Fidelity® funds. Previously, Mr. Lacy served as Senior Adviser (2007-2014) of Oak Hill Capital Partners, L.P. (private equity), Chief Executive Officer (2005) and Vice Chairman (2005-2006) of Sears Holdings Corporation (retail), Chief Executive Officer and Chairman of the Board of Sears, Roebuck and Co. (retail, 2000-2005) and Chairman (2014-2017) and a member of the Board (2010-2017) of Dave & Busters Entertainment, Inc. (restaurant and entertainment complexes). Mr. Lacy currently serves as a member of the Board of Bristol-Myers Squibb Company (global pharmaceuticals, 2008-present), Trustee of the California Chapter of The Nature Conservancy (2015-present) and a member of the Board of the Center for Advanced Study in the Behavioral Sciences at Stanford University (2015-present).
Ned C. Lautenbach (1944)
Year of Election or Appointment: 2018
Trustee
Chairman of the Independent Trustees
Mr. Lautenbach also serves as Trustee of other Fidelity® funds. Mr. Lautenbach currently serves as Chair of the Board of Governors, State University System of Florida (2013-present) and is a member of the Council on Foreign Relations (1994-present). He is also a member and has in the past served as Chairman of the Board of Directors of Artis-Naples (2012-present). Previously, Mr. Lautenbach served as a member and then Lead Director of the Board of Directors of Eaton Corporation (diversified industrial, 1997-2016). He was also a Partner at Clayton, Dubilier & Rice, LLC (private equity investment, 1998-2010); as well as Director of Sony Corporation (2006-2007). In addition, Mr. Lautenbach had a 30-year career with IBM (technology company), during which time he served as Senior Vice President and as a member of the Corporate Executive Committee (1968-1998).
Joseph Mauriello (1944)
Year of Election or Appointment: 2018
Trustee
Mr. Mauriello also serves as Trustee of other Fidelity® funds. Prior to his retirement in January 2006, Mr. Mauriello served in numerous senior management positions including Deputy Chairman and Chief Operating Officer (2004-2005), and Vice Chairman of Financial Services (2002-2004) of KPMG LLP US (professional services, 1965-2005). Mr. Mauriello currently serves as a member of the Independent Directors Council Governing Council (2015-present). Previously, Mr. Mauriello served as a member of the Board of XL Group plc. (global insurance and re-insurance, 2006-2018).
Cornelia M. Small (1944)
Year of Election or Appointment: 2018
Trustee
Ms. Small also serves as Trustee of other Fidelity® funds. Previously, Ms. Small served as Chief Investment Officer, Director of Global Equity Investments and a member of Scudder, Stevens & Clark and Scudder Kemper Investments. Ms. Small previously served as a member of the Board (2009-2019) and Chair of the Investment Committee (2010-2019) of the Teagle Foundation and a member of the Investment Committee of the Berkshire Taconic Community Foundation (2008-2019).
Garnett A. Smith (1947)
Year of Election or Appointment: 2017
Trustee
Mr. Smith also serves as Trustee of other Fidelity® funds. Prior to his retirement, Mr. Smith served as Chairman and Chief Executive Officer (1990-1997) and President (1986-1990) of Inbrand Corp. (manufacturer of personal absorbent products). Prior to his employment with Inbrand Corp., he was employed by a retail fabric chain and North Carolina National Bank (now Bank of America). Mr. Smith previously served as a member of the Advisory Board of certain Fidelity® funds (2012-2013).
David M. Thomas (1949)
Year of Election or Appointment: 2018
Trustee
Mr. Thomas also serves as Trustee of other Fidelity® funds. Previously, Mr. Thomas served as Executive Chairman (2005-2006) and Chairman and Chief Executive Officer (2000-2005) of IMS Health, Inc. (pharmaceutical and healthcare information solutions). Mr. Thomas currently serves as Non-Executive Chairman of the Board of Fortune Brands Home and Security (home and security products, 2011-present), and a member of the Board (2004-present) and Presiding Director (2013-present) of Interpublic Group of Companies, Inc. (marketing communication).
Michael E. Wiley (1950)
Year of Election or Appointment: 2017
Trustee
Mr. Wiley also serves as Trustee or a member of the Advisory Board of other Fidelity® funds. Previously, Mr. Wiley served as Chairman, President and CEO of Baker Hughes, Inc. (oilfield services, 2000-2004). Mr. Wiley currently serves as a member of the Board of High Point Resources (exploration and production, 2005-present). Previously, Mr. Wiley served as a member of the Board of Andeavor Corporation (independent oil refiner and marketer, 2005-2018) and a member of the Board of Andeavor Logistics LP (natural resources logistics, 2015-2018).
+ The information includes the Trustee's principal occupation during the last five years and other information relating to the experience, attributes, and skills relevant to the Trustee's qualifications to serve as a Trustee, which led to the conclusion that the Trustee should serve as a Trustee for the fund.
Advisory Board Members and Officers:
Correspondence intended for a Member of the Advisory Board (if any) may be sent to Fidelity Investments, P.O. Box 55235, Boston, Massachusetts 02205-5235. Correspondence intended for an officer or Peter S. Lynch may be sent to Fidelity Investments, 245 Summer Street, Boston, Massachusetts 02210. Officers appear below in alphabetical order.
Name, Year of Birth; Principal Occupation
Vicki L. Fuller (1957)
Year of Election or Appointment: 2018
Member of the Advisory Board
Ms. Fuller also serves as a member of the Advisory Board of other Fidelity® funds. Previously, Ms. Fuller served as Chief Investment Officer of the New York State Common Retirement Fund (2012-2018) and held a variety of positions at AllianceBernstein L.P. (global asset management, 1985-2012), including Managing Director (2006-2012) and Senior Vice President and Senior Portfolio Manager (2001-2006). Ms. Fuller currently serves as a member of the Board, Audit Committee and Nominating and Governance Committee of The Williams Companies, Inc. (natural gas infrastructure, 2018-present) and as a member of the Board of Treliant, LLC (consulting, 2019-present).
Patricia L. Kampling (1959)
Year of Election or Appointment: 2020
Member of the Advisory Board
Ms. Kampling also serves as Member of the Advisory Board of other Fidelity® funds. Prior to her retirement, Ms. Kampling served as Chairman of the Board and Chief Executive Officer (2012-2019), President and Chief Operating Officer (2011-2012) and Executive Vice President and Chief Financial Officer (2010-2011) of Alliant Energy Corporation. Ms. Kampling currently serves as a member of the Board, Compensation Committee and Executive Committee and as Chair of the Audit Committee of Briggs & Stratton Corporation (manufacturing, 2011-present) and as a member of the Board, Audit, Finance and Risk Committee and Safety, Environmental, Technology and Operations Committee of American Water Works Company, Inc. (utilities company, 2019-present). In addition, Ms. Kampling currently serves as a member of the Board of the Nature Conservancy, Wisconsin Chapter (2019-present). Previously, Ms. Kampling served as a member of the Board of Interstate Power and Light Company (2012-2019) and Wisconsin Power and Light Company (2012-2019) (each a subsidiary of Alliant Energy Corporation) and as a member of the Board and Workforce Development Committee of the Business Roundtable (2018-2019).
Peter S. Lynch (1944)
Year of Election or Appointment: 2018
Member of the Advisory Board
Mr. Lynch also serves as Member of the Advisory Board of other Fidelity® funds. Mr. Lynch is Vice Chairman and a Director of Fidelity Management & Research Company LLC (investment adviser firm). In addition, Mr. Lynch serves as a Trustee of Boston College and as the Chairman of the Inner-City Scholarship Fund. Previously, Mr. Lynch served as Vice Chairman and a Director of FMR Co., Inc. (investment adviser firm) and on the Special Olympics International Board of Directors (1997-2006).
Susan Tomasky (1953)
Year of Election or Appointment: 2020
Member of the Advisory Board
Ms. Tomasky also serves as Member of the Advisory Board of other Fidelity® funds. Prior to her retirement, Ms. Tomasky served in various executive officer positions at American Electric Power Company, Inc. (1998-2011), including most recently as President of AEP Transmission (2007-2011). Ms. Tomasky currently serves as a member of the Board and Sustainability Committee and as Chair of the Audit Committee of Marathon Petroleum Corporation (2018-present) and as a member of the Board, Corporate Governance Committee and Organization and Compensation Committee and as Chair of the Audit Committee of Public Service Enterprise Group, Inc. (utilities company, 2012-present). In addition, Ms. Tomasky currently serves as a member of the Board of the Columbus Regional Airport Authority (2007-present), as a member of the Board of the Royal Shakespeare Company America (2009-present), as a member of the Board of the Columbus Association for the Performing Arts (2011-present) and as a member of the Board of Kenyon College (2016-present). Previously, Ms. Tomasky served as a member of the Board (2011-2019) and as Lead Independent Director (2015-2018) of Andeavor Corporation (previously Tesoro Corporation) (independent oil refiner and marketer) and as a member of the Board of Summit Midstream Partners LP (energy, 2012-2018).
Elizabeth Paige Baumann (1968)
Year of Election or Appointment: 2017
Anti-Money Laundering (AML) Officer
Ms. Baumann also serves as AML Officer of other funds. She is Chief AML Officer (2012-present) and Senior Vice President (2014-present) of FMR LLC (diversified financial services company) and is an employee of Fidelity Investments. Previously, Ms. Baumann served as AML Officer of certain funds (2017-2019), as AML Officer of the funds (2012-2016), and Vice President (2007-2014) and Deputy Anti-Money Laundering Officer (2007-2012) of FMR LLC.
Craig S. Brown (1977)
Year of Election or Appointment: 2019
Assistant Treasurer
Mr. Brown also serves as Assistant Treasurer of other funds. Mr. Brown is an employee of Fidelity Investments (2013-present).
John J. Burke III (1964)
Year of Election or Appointment: 2018
Chief Financial Officer
Mr. Burke also serves as Chief Financial Officer of other funds. Mr. Burke serves as Head of Investment Operations for Fidelity Fund and Investment Operations (2018-present) and is an employee of Fidelity Investments (1998-present). Previously Mr. Burke served as head of Asset Management Investment Operations (2012-2018).
William C. Coffey (1969)
Year of Election or Appointment: 2019
Assistant Secretary
Mr. Coffey also serves as Assistant Secretary of other funds. He is Senior Vice President and Deputy General Counsel of FMR LLC (diversified financial services company, 2010-present), and is an employee of Fidelity Investments. Previously, Mr. Coffey served as Secretary and CLO of certain funds (2018-2019); CLO, Secretary, and Senior Vice President of Fidelity Management & Research Company and FMR Co., Inc. (investment adviser firms, 2018-2019); Secretary of Fidelity SelectCo, LLC and Fidelity Investments Money Management, Inc. (investment adviser firms, 2018-2019); CLO of Fidelity Management & Research (Hong Kong) Limited, FMR Investment Management (UK) Limited, and Fidelity Management & Research (Japan) Limited (investment adviser firms, 2018-2019); and Assistant Secretary of certain funds (2009-2018).
Timothy M. Cohen (1969)
Year of Election or Appointment: 2018
Vice President
Mr. Cohen also serves as Vice President of other funds. Mr. Cohen serves as Co-Head of Equity (2018-present), a Director of Fidelity Management & Research (Japan) Limited (investment adviser firm, 2016-present), and is an employee of Fidelity Investments. Previously, Mr. Cohen served as Executive Vice President of Fidelity SelectCo, LLC (2019), Head of Global Equity Research (2016-2018), Chief Investment Officer - Equity and a Director of Fidelity Management & Research (U.K.) Inc. (investment adviser firm, 2013-2015) and as a Director of Fidelity Management & Research (Hong Kong) Limited (investment adviser firm, 2017).
Jonathan Davis (1968)
Year of Election or Appointment: 2017
Assistant Treasurer
Mr. Davis also serves as Assistant Treasurer of other funds. Mr. Davis serves as Assistant Treasurer of FMR Capital, Inc. (2017-present) and is an employee of Fidelity Investments. Previously, Mr. Davis served as Vice President and Associate General Counsel of FMR LLC (diversified financial services company, 2003-2010).
Laura M. Del Prato (1964)
Year of Election or Appointment: 2018
Assistant Treasurer
Ms. Del Prato also serves as an officer of other funds. Ms. Del Prato is an employee of Fidelity Investments (2017-present). Prior to joining Fidelity Investments, Ms. Del Prato served as a Managing Director and Treasurer of the JPMorgan Mutual Funds (2014-2017). Prior to JPMorgan, Ms. Del Prato served as a partner at Cohen Fund Audit Services (accounting firm, 2012-2013) and KPMG LLP (accounting firm, 2004-2012).
Colm A. Hogan (1973)
Year of Election or Appointment: 2020
Assistant Treasurer
Mr. Hogan also serves as an officer of other funds. Mr. Hogan serves as Assistant Treasurer of FMR Capital, Inc. (2017-present) and is an employee of Fidelity Investments (2005-present). Previously, Mr. Hogan served as Deputy Treasurer of certain Fidelity® funds (2016-2020) and Assistant Treasurer of certain Fidelity® funds (2016-2018).
Pamela R. Holding (1964)
Year of Election or Appointment: 2018
Vice President
Ms. Holding also serves as Vice President of other funds. Ms. Holding serves as Co-Head of Equity (2018-present) and is an employee of Fidelity Investments (2013-present). Previously, Ms. Holding served as Executive Vice President of Fidelity SelectCo, LLC (2019) and as Chief Investment Officer of Fidelity Institutional Asset Management (2013-2018).
Cynthia Lo Bessette (1969)
Year of Election or Appointment: 2019
Secretary and Chief Legal Officer (CLO)
Ms. Lo Bessette also serves as an officer of other funds. Ms. Lo Bessette serves as CLO, Secretary, and Senior Vice President of Fidelity Management & Research Company LLC (investment adviser firm, 2019-present); and CLO of Fidelity Management & Research (Hong Kong) Limited, FMR Investment Management (UK) Limited, and Fidelity Management & Research (Japan) Limited (investment adviser firms, 2019-present). She is a Senior Vice President and Deputy General Counsel of FMR LLC (diversified financial services company, 2019-present), and is an employee of Fidelity Investments. Previously, Ms. Lo Bessette served as CLO, Secretary, and Senior Vice President of FMR Co., Inc. (investment adviser firm, 2019); Secretary of Fidelity SelectCo, LLC and Fidelity Investments Money Management, Inc. (investment adviser firms, 2019). Prior to joining Fidelity Investments, Ms. Lo Bessette was Executive Vice President, General Counsel (2016-2019) and Senior Vice President, Deputy General Counsel (2015-2016) of OppenheimerFunds (investment management company) and Deputy Chief Legal Officer (2013-2015) of Jennison Associates LLC (investment adviser firm).
Chris Maher (1972)
Year of Election or Appointment: 2020
Deputy Treasurer
Mr. Maher also serves as an officer of other funds. Mr. Maher serves as Assistant Treasurer of FMR Capital, Inc. (2017-present), and is an employee of Fidelity Investments (2008-present). Previously, Mr. Maher served as Assistant Treasurer of certain funds (2013-2020); Vice President of Asset Management Compliance (2013), Vice President of the Program Management Group of FMR (investment adviser firm, 2010-2013), and Vice President of Valuation Oversight (2008-2010).
Kenneth B. Robins (1969)
Year of Election or Appointment: 2018
Chief Compliance Officer
Mr. Robins also serves as an officer of other funds. Mr. Robins serves as Compliance Officer of Fidelity Management & Research Company LLC (investment adviser firm, 2016-present) and is an employee of Fidelity Investments (2004-present). Previously, Mr. Robins served as Compliance Officer of FMR Co., Inc. (investment adviser firm, 2016-2019), as Executive Vice President of Fidelity Investments Money Management, Inc. (investment adviser firm, 2013-2016) and served in other fund officer roles.
Stacie M. Smith (1974)
Year of Election or Appointment: 2018
President and Treasurer
Ms. Smith also serves as an officer of other funds. Ms. Smith serves as Assistant Treasurer of FMR Capital, Inc. (2017-present), is an employee of Fidelity Investments (2009-present), and has served in other fund officer roles. Prior to joining Fidelity Investments, Ms. Smith served as Senior Audit Manager of Ernst & Young LLP (accounting firm, 1996-2009). Previously, Ms. Smith served as Assistant Treasurer (2013-2019) and Deputy Treasurer (2013-2016) of certain Fidelity® funds.
Marc L. Spector (1972)
Year of Election or Appointment: 2017
Assistant Treasurer
Mr. Spector also serves as an officer of other funds. Mr. Spector serves as Assistant Treasurer of FMR Capital, Inc. (2017-present) and is an employee of Fidelity Investments (2016-present). Prior to joining Fidelity Investments, Mr. Spector served as Director at the Siegfried Group (accounting firm, 2013-2016), and prior to Siegfried Group as audit senior manager at Deloitte & Touche LLP (accounting firm, 2005-2013).
Jim Wegmann (1979)
Year of Election or Appointment: 2019
Assistant Treasurer
Mr. Wegmann also serves as Assistant Treasurer of other funds. Mr. Wegmann is an employee of Fidelity Investments (2011-present).
Shareholder Expense Example
As a shareholder of the Fund, you incur two types of costs: (1) transaction costs and (2) ongoing costs including management fees and other Fund expenses. This Example is intended to help you understand your ongoing costs (in dollars) of investing in the Fund and to compare these costs with the ongoing costs of investing in other mutual funds.
The Example is based on an investment of $1,000 invested at the beginning of the period and held for the entire period (September 1, 2019 to February 29, 2020).
Actual Expenses
The first line of the accompanying table provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000.00 (for example, an $8,600 account value divided by $1,000.00 = 8.6), then multiply the result by the number in the first line under the heading entitled "Expenses Paid During Period" to estimate the expenses you paid on your account during this period. In addition, the Fund, as a shareholder in the underlying Fidelity Central Funds, will indirectly bear its pro-rata share of the fees and expenses incurred by the underlying Fidelity Central Funds. These fees and expenses are not included in the Fund's annualized expense ratio used to calculate the expense estimate in the table below.
Hypothetical Example for Comparison Purposes
The second line of the accompanying table provides information about hypothetical account values and hypothetical expenses based on the Fund's actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Fund's actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in the Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds. In addition, the Fund, as a shareholder in the underlying Fidelity Central Funds, will indirectly bear its pro-rata share of the fees and expenses incurred by the underlying Fidelity Central Funds. These fees and expenses are not included in the Fund's annualized expense ratio used to calculate the expense estimate in the table below.
Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transaction costs. Therefore, the second line of the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds.
Annualized Expense Ratio-A |
Beginning
Account Value September 1, 2019 |
Ending
Account Value February 29, 2020 |
Expenses Paid
During Period-B September 1, 2019 to February 29, 2020 |
|
Actual | .64% | $1,000.00 | $957.00 | $3.11 |
Hypothetical-C | $1,000.00 | $1,021.68 | $3.22 |
A Annualized expense ratio reflects expenses net of applicable fee waivers.
B Expenses are equal to the Fund's annualized expense ratio, multiplied by the average account value over the period, multiplied by 182/366 (to reflect the one-half year period).
C 5% return per year before expenses
Distributions (Unaudited)
The fund designates 99% of the dividends distributed in December, during the fiscal year as qualifying for the dividendsreceived deduction for corporate shareholders.
The fund designates 100% of the dividends distributed in December, during the fiscal year as amounts which may be taken into account as a dividend for the purposes of the maximum rate under section 1(h)(11) of the Internal Revenue Code.
The fund will notify shareholders in January 2021 of amounts for use in preparing 2020 income tax returns.
Board Approval of Investment Advisory Contracts and Management Fees
Fidelity Small Cap Enhanced Index Fund
Each year, the Board of Trustees, including the Independent Trustees (together, the Board), votes on the renewal of the management contract with Fidelity Management & Research Company LLC (FMR) and the sub-advisory agreement (Sub-Advisory Agreement) for the fund with Geode Capital Management, LLC (Geode) (together, the Advisory Contracts). FMR and Geode are referred to herein as the Investment Advisers. The Board, assisted by the advice of fund counsel and Independent Trustees' counsel, requests and considers a broad range of information relevant to the renewal of the Advisory Contracts throughout the yearApproval of Amended and Restated Advisory Contracts. At its November 2019 meeting, the Board unanimously determined to approve an amended and restated management contract and sub-advisory agreements (Amended and Restated Contracts) for a stub period of January 1, 2020 through January 31, 2020 in connection with a consolidation of certain of Fidelity's advisory businesses. The Board considered that, on or about January 1, 2020, FMR Co., Inc. (FMRC) expected to merge with and into FMR and, after the merger, FMR expected to redomicile as a Delaware limited liability company. The Board noted that the Amended and Restated Contracts will reflect the replacement of FMRC with FMR and will take effect upon the completion of the merger. The Board noted that references to FMR in the Amended and Restated Contracts would be updated to reflect FMR's new form of organization and domicile and that the sub-advisory agreement would reflect removal of a fee aggregation provision not currently in effect. The Board also noted Fidelity's assurance that neither the planned consolidation nor the Amended and Restated Contracts will change the investment processes, the level or nature of services provided, the resources and personnel allocated, trading and compliance operations, or any fees paid by the fund.
The Board meets regularly and, at each of its meetings, covers an extensive agenda of topics and materials and considers factors that are relevant to its annual consideration of the renewal of the fund's Advisory Contracts, including the services and support provided to the fund and its shareholders. The Board has established various standing committees (Committees), each composed of and chaired by Independent Trustees with varying backgrounds, to which the Board has assigned specific subject matter responsibilities in order to enhance effective decision-making by the Board. The Board, acting directly and through its Committees, requests and receives information concerning the annual consideration of the renewal of the fund's Advisory Contracts. The Board also meets as needed to review matters specifically related to the Board's annual consideration of the renewal of the Advisory Contracts. Members of the Board may also meet with trustees of other Fidelity funds through joint ad hoc committees to discuss certain matters relevant to all of the Fidelity funds.
At its January 2020 meeting, the Board unanimously determined to renew the fund's Advisory Contracts. In reaching its determination, the Board considered all factors it believed relevant, including (i) the nature, extent, and quality of the services provided to the fund and its shareholders (including the investment performance of the fund); (ii) the competitiveness of the fund's management fee and total expense ratio relative to peer funds; (iii) the total costs of the services provided by and the profits realized by Fidelity and Geode from their respective relationships with the fund; and (iv) the extent to which, if any, economies of scale exist and are realized as the fund grows, and whether any economies of scale are appropriately shared with fund shareholders.
In considering whether to renew the Advisory Contracts for the fund, the Board reached a determination, with the assistance of fund counsel and Independent Trustees' counsel and through the exercise of its business judgment, that the renewal of the Advisory Contracts was in the best interests of the fund and its shareholders and that the compensation payable under the Advisory Contracts was fair and reasonable. The Board's decision to renew the Advisory Contracts was not based on any single factor, but rather was based on a comprehensive consideration of all the information provided to the Board at its meetings throughout the year. The Board, in reaching its determination to renew the Advisory Contracts, was aware that shareholders of the fund have a broad range of investment choices available to them, including a wide choice among funds offered by Fidelity's competitors, and that the fund's shareholders, who have the opportunity to review and weigh the disclosure provided by the fund in its prospectus and other public disclosures, have chosen to invest in this fund, which is part of the Fidelity family of funds.
Nature, Extent, and Quality of Services Provided. The Board considered staffing as it relates to the fund, including the backgrounds of investment personnel of Fidelity and Geode, and also considered the fund's investment objective, strategies, and related investment philosophy. The Independent Trustees also had discussions with senior management of Fidelity's investment operations and investment groups and with representatives of Geode. The Board considered the structure of the investment personnel compensation programs and whether the structures provide appropriate incentives to act in the best interests of the fund. Additionally, the Board considered the portfolio managers' investments, if any, in the funds that they manage.
The Trustees also discussed with representatives of Fidelity, at meetings throughout the year, Fidelity's role in, among other things, overseeing compliance with federal securities laws and other applicable requirements by Geode with respect to the fund and monitoring and overseeing the performance and investment capabilities of Geode. The Trustees considered that the Board had received from Fidelity periodic reports about its oversight and due diligence processes, as well as periodic reports regarding the performance of Geode.
The Board also considered the nature, extent and quality of services provided by Geode. The Trustees noted that under the Sub-Advisory Agreement, subject to oversight by Fidelity, Geode is responsible for, among other things, identifying investments and arranging for execution of portfolio transactions to implement the fund's investment strategy. In addition, the Trustees noted that Geode is responsible for providing such reporting as may be requested by Fidelity to fulfill its oversight responsibilities discussed above.
Resources Dedicated to Investment Management and Support Services. The Board and the Fund Oversight and Research Committees reviewed the general qualifications and capabilities of Fidelity's and Geode's investment staffs, including their size, education, experience, and resources, as well as Fidelity's and Geode's approach to recruiting, training, managing, and compensating investment personnel. The Board considered that Fidelity's and Geode's investment professionals have extensive resources, tools and capabilities so as to provide competitive investment results over time, and that those professionals also have access to sophisticated tools that permit them to assess portfolio construction and risk and performance attribution characteristics continuously. Additionally, in its deliberations, the Board considered Fidelity's and Geode's trading, risk management, compliance, and technology and operations capabilities and resources, which are integral parts of the investment management process.
Shareholder and Administrative Services. The Board considered (i) the nature, extent, quality, and cost of advisory, administrative, and shareholder services performed by the Investment Advisers and their affiliates under the Advisory Contracts and by FMR's affiliates under separate agreements covering transfer agency, pricing and bookkeeping, and securities lending services for the fund; (ii) the nature and extent of the supervision of third party service providers, principally custodians, subcustodians, and pricing vendors; and (iii) the resources devoted to, and the record of compliance with, the fund's compliance policies and procedures. The Board also reviewed the allocation of fund brokerage, including allocations to brokers affiliated with the Investment Advisers.
The Board noted that the growth of fund assets over time across the complex allows Fidelity to reinvest in the development of services designed to enhance the value and convenience of the Fidelity funds as investment vehicles. These services include 24-hour access to account information and market information over the Internet and through telephone representatives, investor education materials and asset allocation tools, and the expanded availability of Fidelity Investor Centers.
Investment in a Large Fund Family. The Board considered the benefits to shareholders of investing in a Fidelity fund, including the benefits of investing in a fund that is part of a large family of funds offering a variety of investment disciplines and providing a large variety of mutual fund investor services. The Board noted that Fidelity had taken, or had made recommendations that resulted in the Fidelity funds taking, a number of actions over the previous year that benefited particular funds, including: (i) continuing to dedicate additional resources to Fidelity's investment research process, which includes meetings with management of issuers of securities in which the funds invest, and to the support of the senior management team that oversees asset management; (ii) continuing efforts to enhance Fidelity's global research capabilities; (iii) launching new funds and ETFs with innovative structures, strategies and pricing and making other enhancements to meet client needs; (iv) launching new share classes of existing funds; (v) eliminating purchase minimums and broadening eligibility requirements for certain funds and share classes; (vi) reducing management fees and total expenses for certain target date funds and index funds; (vii) lowering expense caps for certain existing funds and classes, and converting certain voluntary expense caps to contractual caps, to reduce expenses borne by shareholders; (viii) rationalizing product lines and gaining increased efficiencies from fund mergers, liquidations, and share class consolidations; (ix) continuing to develop, acquire and implement systems and technology to improve services to the funds and shareholders, strengthen information security, and increase efficiency; and (x) continuing to implement enhancements to further strengthen Fidelity's product line to increase investors' probability of success in achieving their investment goals, including retirement income goals.
Investment Performance. The Board considered whether the fund has operated in accordance with its investment objective, as well as its record of compliance with its investment restrictions and its performance history.
The Board took into account discussions that occur at Board meetings throughout the year with representatives of the Investment Advisers about fund investment performance. In this regard the Board noted that as part of regularly scheduled fund reviews and other reports to the Board on fund performance, the Board considers annualized return information for the fund for different time periods, measured against an appropriate securities market index (benchmark index) and a peer group of funds with similar objectives (peer group), if any. In its evaluation of fund investment performance, the Board gave particular attention to information indicating changes in performance of certain Fidelity funds for specific time periods and discussed with the Investment Advisers the reasons for any overperformance or underperformance.
In addition to reviewing absolute and relative fund performance, the Independent Trustees periodically consider the appropriateness of fund performance metrics in evaluating the results achieved. In general, the Independent Trustees believe that fund performance should be evaluated based on net performance (after fees and expenses) of both the highest performing and lowest performing fund share classes, where applicable, compared to appropriate benchmark indices, over appropriate time periods that may include full market cycles, and compared to peer groups, as applicable, over the same periods, taking into account relevant factors including the following: general market conditions; issuer-specific information; and fund cash flows and other factors.
The Independent Trustees recognize that shareholders evaluate performance on a net basis over their own holding periods, for which one-, three-, and five-year periods are often used as a proxy. For this reason, the performance information reviewed by the Board also included net cumulative total return information for the fund and an appropriate benchmark index and peer group for the most recent one-, three-, and five-year periods ended June 30, 2019, as shown below. Returns are shown compared to the 25th percentile (top of box, 75% beaten) and 75th percentile (bottom of box, 25% beaten) of the peer universe.
Fidelity Small Cap Enhanced Index Fund
Based on its review, the Board concluded that the nature, extent, and quality of services provided to the fund under the Advisory Contracts should continue to benefit the shareholders of the fund.
Competitiveness of Management Fee and Total Expense Ratio. The Board considered the fund's management fee and total expense ratio compared to "mapped groups" of competitive funds and classes created for the purpose of facilitating the Trustees' competitive analysis of management fees and total expenses. Fidelity creates "mapped groups" by combining similar Lipper investment objective categories that have comparable investment mandates. Combining Lipper investment objective categories aids the Board's management fee and total expense ratio comparisons by broadening the competitive group used for comparison.
Management Fee. The Board considered two proprietary management fee comparisons forthe 12-month periods ended June 30 (December 31 for periods prior to 2018) shown in basis points (BP) in the chart below. The group of Lipper funds used by the Board for management fee comparisons is referred to below as the "Total Mapped Group." The Total Mapped Group is broader than the Lipper peer group used by the Board for performance comparisons because the Total Mapped Group combines several Lipper investment objective categories while the Lipper peer group does not. The Total Mapped Group comparison focuses on a fund's standing in terms of gross management fees before expense reimbursements or caps relative to the total universe of funds with comparable investment mandates, regardless of whether their management fee structures also are comparable. Funds with comparable investment mandates offer exposure to similar types of securities. Funds with comparable management fee structures have similar management fee contractual arrangements (e.g., flat rate charged for advisory services, all-inclusive fee rate, etc.). "TMG %" represents the percentage of funds in the Total Mapped Group that had management fees that were lower than the fund's. For example, a hypothetical TMG % of 20% would mean that 80% of the funds in the Total Mapped Group had higher, and 20% had lower, management fees than the fund. The fund's actual TMG %s and the number of funds in the Total Mapped Group are in the chart below. The "Asset-Sized Peer Group" (ASPG) comparison focuses on a fund's standing relative to a subset of non-Fidelity funds within the Total Mapped Group that are similar in size and management fee structure. For example, if a fund is in the first quartile of the ASPG, the fund's management fee ranks in the least expensive or lowest 25% of funds in the ASPG. The ASPG represents at least 15% of the funds in the Total Mapped Group with comparable asset size and management fee structures, subject to a minimum of 50 funds (or all funds in the Total Mapped Group if fewer than 50). Additional information, such as the ASPG quartile in which the fund's management fee rate ranked, is also included in the chart and was considered by the Board. Because the vast majority of competitor funds' management fees do not cover non-management expenses, in prior years, the fund was compared on the basis of a hypothetical "net management fee," which was derived by subtracting payments made by FMR for non-management expenses (including transfer agent fees, pricing and bookkeeping fees and fees paid to non-affiliated custodians) from the fund's management fee. Given the fund's competitive management fee rates, Fidelity no longer calculates a hypothetical net management fee for the fund and, as a result, the chart does not include a hypothetical net management fee for periods after 2016. With respect to the historical net management fee information, the Board considered that non-management expenses may exceed the fund's all-inclusive fee and result in a negative net management fee.
Fidelity Small Cap Enhanced Index Fund
The Board considered that a new management contract for the fund that implemented an all-inclusive management fee structure had taken effect April 1, 2017, following approval by shareholders. Under this new fee structure, the management fee rate for the fund increased from 0.52% to 0.64%, and FMR now pays all other expenses of the fund with limited exceptions. The Board noted that as a result of the new fee structure, total expenses incurred by shareholders decreased. The Board also noted that the comparisons for 2015 and later reflect a revised Total Mapped Group that no longer includes funds with micro-cap objectives and that Fidelity believes this Total Mapped Group is a more appropriate comparison because the fund does not have a micro-cap objective.
The Board noted that it and the boards of other Fidelity funds formed an ad hoc Committee on Group Fee, which meets periodically, to conduct an in-depth review of the "group fee" component of the management fee of funds with such management fee structures. The Committee's focus included the mechanics of the group fee, the competitive landscape of group fee structures, Fidelity funds with no group fee component (such as the fund) and investment products not included in group fee assets. The Board also considered that, for funds subject to the group fee, FMR agreed to voluntarily waive fees over a specified period of time in amounts designed to account for assets converted from certain funds to certain collective investment trusts.
Based on its review, the Board concluded that the fund's management fee is fair and reasonable in light of the services that the fund receives and the other factors considered.
Total Expense Ratio. In its review of the fund's total expense ratio, the Board considered the fund's all-inclusive fee rate. The Board also considered other expenses, such astransfer agent fees, pricing and bookkeeping fees, and custodial, legal, and audit fees, paid by the investment adviser under the all-inclusive arrangement. The Board also noted that Fidelity may agree to waive fees or reimburse expenses from time to time, and the extent to which, if any, it has done so for the fund. As part of its review, the Board also considered the current and historical total expense ratios of the fund compared to competitive fund median expenses. The fund is compared to those funds in the Total Mapped Group (used by the Board for management fee comparisons) that have a similar sales load structure.
The Board noted that the fund's total expense ratio ranked below the competitive median for the 12-month period ended June 30, 2019.
Fees Charged to Other Clients. The Board also considered fee structures applicable to clients of Fidelity and Geode, such as other funds advised or subadvised by Fidelity or Geode, pension plan clients, and other institutional clients with similar mandates. The Board noted that a joint ad hoc committee created by it and the boards of other Fidelity funds periodically reviews and compares Fidelity's institutional investment advisory business with its business of providing services to the Fidelity funds and also noted the most recent findings of the committee. The Board noted that the committee's review included a consideration of the differences in services provided, fees charged, and costs incurred, as well as competition in the markets serving the different categories of clients.
Based on its review of total expense ratios and fees charged to other Fidelity clients, the Board concluded that the fund's total expense ratio was reasonable in light of the services that the fund and its shareholders receive and the other factors considered.
Costs of the Services and Profitability. The Board consideredthe revenues earned and the expenses incurred by Fidelity in conducting the business of developing, marketing, distributing, managing, administering and servicing the fund and servicing the fund's shareholders. The Board also considered the level of Fidelity's profits in respect of all the Fidelity funds.
On an annual basis, Fidelity presents to the Board information about the profitability of its relationships with the fund. Fidelity calculates profitability information for each fund, as well as aggregate profitability information for groups of Fidelity funds and all Fidelity funds, using a series of detailed revenue and cost allocation methodologies which originate with the books and records of Fidelity on which Fidelity's audited financial statements are based. The Audit Committee of the Board reviews any significant changes from the prior year's methodologies and the full Board approves such changes.
PricewaterhouseCoopers LLP (PwC), auditor to Fidelity and certain Fidelity funds, has been engaged annually by the Board as part of the Board's assessment of Fidelity's profitability analysis. PwC's engagement includes the review and assessment of the methodologies used by Fidelity in determining the revenues and expenses attributable to Fidelity's mutual fund business, and completion of agreed-upon procedures in respect of the mathematical accuracy of the fund profitability information and its conformity to established allocation methodologies. After considering PwC's reports issued under the engagement and information provided by Fidelity, the Board concluded that while other allocation methods may also be reasonable, Fidelity's profitability methodologies are reasonable in all material respects.
The Board also reviewed Fidelity's and Geode's non-fund businesses and potential indirect benefits such businesses may have received as a result of their association with Fidelity's mutual fund business (i.e., fall-out benefits) as well as cases where Fidelity's and Geode's affiliates may benefit from the funds' business. The Board noted that changes to fall-out benefits year-over-year reflect business developments at Fidelity's and Geode's various businesses. The Board considered that a joint ad hoc committee created by it and the boards of other Fidelity funds had recently been established, and met periodically, to evaluate potential fall-out benefits (PFOB Committee). The Board noted that the PFOB Committee, among other things: (i) discussed the legal framework surrounding potential fall-out benefits; (ii) reviewed the Board's responsibilities and approach to potential fall-out benefits; and (iii) reviewed practices employed by competitor funds regarding the review of potential fall-out benefits.
The Board considered the costs of the services provided by and the profits realized by Fidelity in connection with the operation of the fund, including the conclusions of the PFOB Committee, and was satisfied that the profitability was not excessive.
The Board also considered information regarding the profitability of Geode's relationship with the fund.
Economies of Scale. The Board considered whether there have been economies of scale in respect of the management of the Fidelity funds, whether the Fidelity funds (including the fund) have appropriately benefited from any such economies of scale, and whether there is potential for realization of any further economies of scale. The Board considered the extent to which the fund will benefit from economies of scale as assets grow through increased services to the fund, through waivers or reimbursements, or through fee or expense ratio reductions. The Board recognized that, due to the fund's current contractual arrangements, its expense ratio will not decline if the fund's operating costs decrease as assets grow, or rise as assets decrease. The Board also noted that a committee (the Economies of Scale Committee) created by it and the boards of other Fidelity funds periodically analyzes whether Fidelity attains economies of scale in respect of the management and servicing of the Fidelity funds, whether the Fidelity funds have appropriately benefited from such economies of scale, and whether there is potential for realization of any further economies of scale.
The Board concluded, taking into account the analysis of the Economies of Scale Committee, that economies of scale, if any, are being appropriately shared between fund shareholders and Fidelity.
Additional Information Requested by the Board. In order to develop fully the factual basis for consideration of the Fidelity funds' advisory contracts, the Board requested and received additional information on certain topics, including: (i) fund flow and performance trends, in particular the underperformance of certain funds and strategies, and Fidelity's long-term strategies for certain funds; (ii) consideration of performance fees for additional funds; (iii) changes in Fidelity's non-fund businesses and the impact of such changes on the funds; (iv) metrics for evaluating index fund and ETF performance and information about ETF trading characteristics; (v) the methodology with respect to evaluating competitive fund data and peer group classifications and fee comparisons; (vi) the expense structures for different funds and classes; (vii) information regarding other accounts managed by Fidelity, including collective investment trusts and separately managed accounts; and (viii) Fidelity's philosophies and strategies for evaluating funds and classes with lower or declining asset levels.
Based on its evaluation of all of the conclusions noted above, and after considering all factors it believed relevant, the Board concluded that the advisory and sub-advisory fee arrangements are fair and reasonable, and that the fund's Amended and Restated Contracts should be approved and the fund's Advisory Contracts should be renewed.
Liquidity Risk Management Program
The Securities and Exchange Commission adopted Rule 22e-4 under the Investment Company Act of 1940 (the Liquidity Rule) to promote effective liquidity risk management throughout the open-end investment company industry, thereby reducing the risk that funds will be unable to meet their redemption obligations and mitigating dilution of the interests of fund shareholders.
The Fund has adopted and implemented a liquidity risk management program pursuant to the Liquidity Rule (the Program) effective December 1, 2018. The Program is reasonably designed to assess and manage the Funds liquidity risk and to comply with the requirements of the Liquidity Rule. The Funds Board of Trustees (the Board) has designated the Funds investment adviser as administrator of the Program. The Fidelity advisers have established a Liquidity Risk Management Committee (the LRM Committee) to manage the Program for each of the Fidelity Funds. The LRM Committee monitors the adequacy and effectiveness of implementation of the Program and on a periodic basis assesses each Funds liquidity risk based on a variety of factors including (1) the Funds investment strategy, (2) portfolio liquidity and cash flow projections during normal and reasonably foreseeable stressed conditions, (3) shareholder redemptions, (4) borrowings and other funding sources and (5) in the case of exchange-traded funds, certain additional factors including the effect of the Funds prices and spreads, market participants, and basket compositions on the overall liquidity of the Funds portfolio, as applicable.
In accordance with the Program, each of the Funds portfolio investments is classified into one of four liquidity categories described below based on a determination of a reasonable expectation for how long it would take to convert the investment to cash (or sell or dispose of the investment) without significantly changing its market value.
Liquidity classification determinations take into account a variety of factors including various market, trading and investment-specific considerations, as well as market depth, and generally utilize analysis from a third-party liquidity metrics service.
The Liquidity Rule places a 15% limit on a funds illiquid investments and requires funds that do not primarily hold assets that are highly liquid investments to determine and maintain a minimum percentage of the funds net assets to be invested in highly liquid investments (highly liquid investment minimum or HLIM). The Program includes provisions reasonably designed to comply with the 15% limit on illiquid investments and for determining, periodically reviewing and complying with the HLIM requirement as applicable.
At a recent meeting of the Funds Board of Trustees, the LRM Committee provided a written report to the Board pertaining to the operation, adequacy, and effectiveness of implementation of the Program for the annual period from December 1, 2018 through November 30, 2019. The report concluded that the Program has been implemented and is operating effectively and is reasonably designed to assess and manage the Funds liquidity risk.
SCE-ANN-0420
1.9885266.103
Item 2.
Code of Ethics
As of the end of the period, February 29, 2020, Fidelity Commonwealth Trust II (the trust) has adopted a code of ethics, as defined in Item 2 of Form N-CSR, that applies to its President and Treasurer and its Chief Financial Officer. A copy of the code of ethics is filed as an exhibit to this Form N-CSR.
Item 3.
Audit Committee Financial Expert
The Board of Trustees of the trust has determined that Joseph Mauriello is an audit committee financial expert, as defined in Item 3 of Form N-CSR. Mr. Mauriello is independent for purposes of Item 3 of Form N-CSR.
Item 4.
Principal Accountant Fees and Services
Fees and Services
The following table presents fees billed by PricewaterhouseCoopers LLP (PwC) in each of the last two fiscal years for services rendered to Fidelity Small Cap Enhanced Index Fund (the Fund):
Services Billed by PwC
February 29, 2020 FeesA
|
Audit Fees |
Audit-Related Fees |
Tax Fees |
All Other Fees |
Fidelity Small Cap Enhanced Index Fund |
$43,100 |
$3,600 |
$3,400 |
$1,500 |
February 28, 2019 FeesA
|
Audit Fees |
Audit-Related Fees |
Tax Fees |
All Other Fees |
Fidelity Small Cap Enhanced Index Fund |
$45,000 |
$3,500 |
$3,500 |
$1,700 |
A Amounts may reflect rounding.
The following table(s) present(s) fees billed by PwC that were required to be approved by the Audit Committee for services that relate directly to the operations and financial reporting of the Fund(s) and that are rendered on behalf of Fidelity Management & Research Company LLC ("FMR") and entities controlling, controlled by, or under
common control with FMR (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser) that provide ongoing services to the Fund(s) (Fund Service Providers):
Services Billed by PwC
|
February 29, 2020A |
February 28, 2019A |
Audit-Related Fees |
$7,927,700 |
$7,930,000 |
Tax Fees |
$28,000 |
$15,000 |
All Other Fees |
$- |
$- |
A Amounts may reflect rounding.
Audit-Related Fees represent fees billed for assurance and related services that are reasonably related to the performance of the fund audit or the review of the fund's financial statements and that are not reported under Audit Fees.
Tax Fees represent fees billed for tax compliance, tax advice or tax planning that relate directly to the operations and financial reporting of the fund.
All Other Fees represent fees billed for services provided to the fund or Fund Service Provider, a significant portion of which are assurance related, that relate directly to the operations and financial reporting of the fund, excluding those services that are reported under Audit Fees, Audit-Related Fees or Tax Fees.
Assurance services must be performed by an independent public accountant.
* * *
The aggregate non-audit fees billed by PwC for services rendered to the Fund(s), FMR (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser), and any Fund Service Provider for each of the last two fiscal years of the Fund(s) are as follows:
Billed By |
February 29, 2020A |
February 28, 2019A |
PwC |
$12,601,900 |
$11,130,000 |
A Amounts may reflect rounding.
The trust's Audit Committee has considered non-audit services that were not pre-approved that were provided by PwC to Fund Service Providers to be compatible with maintaining the independence of PwC in its(their) audit of the Fund(s), taking into account representations from PwC, in accordance with Public Company Accounting Oversight Board rules, regarding its independence from the Fund(s) and its(their) related
entities and FMRs review of the appropriateness and permissibility under applicable law of such non-audit services prior to their provision to the Fund(s) Service Providers.
Audit Committee Pre-Approval Policies and Procedures
The trusts Audit Committee must pre-approve all audit and non-audit services provided by a funds independent registered public accounting firm relating to the operations or financial reporting of the fund. Prior to the commencement of any audit or non-audit services to a fund, the Audit Committee reviews the services to determine whether they are appropriate and permissible under applicable law.
The Audit Committee has adopted policies and procedures to, among other purposes, provide a framework for the Committees consideration of non-audit services by the audit firms that audit the Fidelity funds. The policies and procedures require that any non-audit service provided by a fund audit firm to a Fidelity fund and any non-audit service provided by a fund auditor to a Fund Service Provider that relates directly to the operations and financial reporting of a Fidelity fund (Covered Service) are subject to approval by the Audit Committee before such service is provided.
All Covered Services must be approved in advance of provision of the service either: (i) by formal resolution of the Audit Committee, or (ii) by oral or written approval of the service by the Chair of the Audit Committee (or if the Chair is unavailable, such other member of the Audit Committee as may be designated by the Chair to act in the Chairs absence). The approval contemplated by (ii) above is permitted where the Treasurer determines that action on such an engagement is necessary before the next meeting of the Audit Committee.
Non-audit services provided by a fund audit firm to a Fund Service Provider that do not relate directly to the operations and financial reporting of a Fidelity fund are reported to the Audit Committee periodically.
Non-Audit Services Approved Pursuant to Rule 2-01(c)(7)(i)(C) and (ii) of Regulation S-X (De Minimis Exception)
There were no non-audit services approved or required to be approved by the Audit Committee pursuant to the De Minimis Exception during the Funds(s) last two fiscal years relating to services provided to (i) the Fund(s) or (ii) any Fund Service Provider that relate directly to the operations and financial reporting of the Fund(s).
Item 5.
Audit Committee of Listed Registrants
Not applicable.
Item 6.
Investments
(a)
Not applicable.
(b)
Not applicable.
Item 7.
Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies
Not applicable.
Item 8.
Portfolio Managers of Closed-End Management Investment Companies
Not applicable.
Item 9.
Purchase of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers
Not applicable.
Item 10.
Submission of Matters to a Vote of Security Holders
There were no material changes to the procedures by which shareholders may recommend nominees to the trusts Board of Trustees.
Item 11.
Controls and Procedures
(a)(i) The President and Treasurer and the Chief Financial Officer have concluded that the trusts disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act) provide reasonable assurances that material information relating to the trust is made known to them by the appropriate persons, based on their evaluation of these controls and procedures as of a date within 90 days of the filing date of this report.
(a)(ii) There was no change in the trusts internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the trusts internal control over financial reporting.
Item 12.
Disclosure of Securities Lending Activities for Closed-End Management
Investment Companies
Not applicable.
Item 13.
Exhibits
(a) |
(1) |
Code of Ethics pursuant to Item 2 of Form N-CSR is filed and attached hereto as EX-99.CODE ETH. |
(a) |
(2) |
|
(a) |
(3) |
Not applicable. |
(b) |
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Fidelity Commonwealth Trust II
By: |
/s/Stacie M. Smith |
|
Stacie M. Smith |
|
President and Treasurer |
|
|
Date: |
April 21, 2020 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By: |
/s/Stacie M. Smith |
|
Stacie M. Smith |
|
President and Treasurer |
|
|
Date: |
April 21, 2020 |
By: |
/s/John J. Burke III |
|
John J. Burke III |
|
Chief Financial Officer |
|
|
Date: |
April 21, 2020 |
EXHIBIT EX-99.CODE ETH
FIDELITY FUNDS CODE OF ETHICS FOR
PRESIDENT, TREASURER AND PRINCIPAL ACCOUNTING OFFICER
I. Purposes of the Code/Covered Officers
This document constitutes the Code of Ethics (Code) adopted by the Fidelity Funds (Funds) pursuant to the provisions of Rule 30b2-1(a) under the Investment Company Act of 1940), which Rule implements Sections 406 of the Sarbanes-Oxley Act of 2002 with respect to registered investment companies. The Code applies to the Fidelity Funds President and Treasurer, and Chief Financial Officer (Covered Officers). Fidelitys Ethics Office, a part of Corporate Compliance Group within Core Compliance, administers the Code.
The purposes of the Code are to deter wrongdoing and to promote, on the part of the Covered Officers:
·
honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;
·
full, fair, accurate, timely and understandable disclosure in reports and documents that the Fidelity Funds submit to the Securities and Exchange Commission (SEC), and in other public communications by a Fidelity Fund;
·
compliance with applicable laws and governmental rules and regulations;
·
the prompt internal reporting to an appropriate person or persons identified in the Code of violations of the Code; and
·
accountability for adherence to the Code.
Each Covered Officer should adhere to a high standard of business ethics and should be sensitive to situations that may give rise to actual as well as apparent conflicts of interest.
II.
Covered Officers Should Handle Ethically
Actual and Apparent Conflicts of Interest
Overview. A conflict of interest occurs when a Covered Officers private interest interferes with the interests of, or his service to, the Fidelity Funds. For example, a conflict of interest would arise if a Covered Officer, or a member of his family, receives improper personal benefits as a result of his position with the Fidelity Funds.
Certain conflicts of interest arise out of the relationships between Covered Officers and the Fidelity Funds and already are subject to conflict of interest provisions in the Investment Company Act of 1940 (Investment Company Act) and the Investment Advisers Act of 1940 (Investment Advisers Act). For example, Covered Officers may not individually engage in certain transactions (such as the purchase or sale of securities or other property) with a Fidelity Fund because of their status as affiliated persons of the Fund. Separate compliance programs and procedures of the Fidelity Funds, Fidelity Management & Research Company (FMR) and the other Fidelity companies are designed to prevent, or identify and correct, violations of these provisions. This Code does not, and is not intended to, repeat or replace these programs and procedures, and such conflicts fall outside of the parameters of this Code.
Although typically not presenting an opportunity for improper personal benefit, conflicts arise from, or as a result of, the contractual relationship between the Fidelity Funds and FMR (or another Fidelity company) of which the Covered Officers are also officers or employees. As a result, this Code recognizes that the Covered Officers will, in the normal course of their duties (whether formally for the Fidelity Funds, FMR or another Fidelity company), be involved in establishing policies and implementing decisions that have different effects on the Fidelity Funds, FMR and other Fidelity companies. The participation of the Covered Officers in such activities is inherent in the contractual relationship between the Fidelity Funds and FMR (or another Fidelity company), and is consistent with the performance by the Covered Officers of their duties as officers of the Fidelity Funds. Thus, if performed in conformity with the provisions of the Investment Company Act and the Investment Advisers Act, such activities will be deemed to have been handled ethically. In addition, it is recognized by the Funds Board of Trustees (Board) that the Covered Officers also may be officers or employees of one or more other Fidelity Funds covered by this Code.
Other conflicts of interest are covered by the Code, even if such conflicts of interest are not subject to provisions in the Investment Company Act and the Investment Advisers Act. The following list provides examples of conflicts of interest under the Code, but Covered Officers should keep in mind that these examples are not exhaustive. The overarching principle is that the personal interest of a Covered Officer should not be placed improperly before the interest of a Fidelity Fund.
* * *
Each Covered Officer must:
·
not use his or her personal influence or personal relationships improperly to influence investment decisions or financial reporting by any Fidelity Fund whereby the Covered Officer would benefit personally to the detriment of any Fidelity Fund;
·
not cause a Fidelity Fund to take action, or fail to take action, for the individual personal benefit of the Covered Officer rather than the benefit of the Fidelity Fund;
·
not engage in any outside business activity, including serving as a director or trustee, that prevents the Covered Officer from devoting appropriate time and attention to the Covered Officers responsibilities with the Fidelity Funds;
·
not have a consulting or employment relationship with any of the Fidelity Funds service providers that are not affiliated with Fidelity; and
·
not retaliate against any employee or Covered Officer for reports of actual or potential misconduct, which are made in good faith.
With respect to other fact patterns, if a Covered Officer is in doubt, other potential conflict of interest situations should be described immediately to the Fidelity Ethics Office for resolution. Similarly, any questions a Covered Officer has generally regarding the application or interpretation of the Code should be directed to the Fidelity Ethics Office immediately.
III. Disclosure and Compliance
·
Each Covered Officer should familiarize himself with the disclosure requirements generally applicable to the Fidelity Funds.
·
Each Covered Officer should not knowingly misrepresent, or cause others to misrepresent, facts about any Fidelity Fund to others, whether within or outside Fidelity, including to the Board and auditors, and to governmental regulators and self-regulatory organizations;
·
Each Covered Officer should, to the extent appropriate within his area of responsibility, consult with other officers and employees of the Fidelity Funds, FMR and the Fidelity service providers, and with the Boards Compliance Committee, with the goal of promoting full, fair, accurate, timely and understandable disclosure in the reports and documents the Fidelity Funds file with, or submit to, the SEC and in other public communications made by the Fidelity Funds; and
·
It is the responsibility of each Covered Officer to promote compliance with the standards and restrictions imposed by applicable laws, rules and regulations.
IV. Reporting and Accountability
Each Covered Officer must:
·
upon receipt of the Code, and annually thereafter, submit to the Fidelity Ethics Office an acknowledgement stating that he or she has received, read, and understands the Code; and
·
notify the Fidelity Ethics Office promptly if he or she knows of any violation of the Code. Failure to do so is itself a violation of this Code.
The Fidelity Ethics Office shall take all action it considers appropriate to investigate any actual or potential violations reported to it. Upon completion of the investigation, if necessary, the matter will be reviewed with senior management or other appropriate parties, and a determination will be made as to whether any action should be taken as detailed below. The Covered Officer will be informed of any action determined to be appropriate. The Fidelity Ethics Office will inform the Personal Trading Committee of all Code violations and actions taken in response. Without implied limitation, appropriate remedial, disciplinary or preventive action may include a written warning, a letter of censure, suspension, dismissal or, in the event of criminal or other serious violations of law, notification of the SEC or other appropriate law enforcement authorities. Additionally, other legal remedies may be pursued.
The policies and procedures described in the Code do not create any obligations to any person or entity other than the Fidelity Funds. The Code is intended solely for the internal use by the Fidelity Funds and does not constitute a promise, contract or an admission by or on behalf of any Fidelity Fund as to any fact, circumstance, or legal conclusion. The Fidelity Funds, the Fidelity companies and the Fidelity Chief Ethics Officer retain the discretion to decide whether the Code applies to a specific situation, and how it should be interpreted.
V. Oversight
Material violations of this Code will be reported promptly by FMR to the Boards Compliance Committee. In addition, at least once each year, FMR will provide a written report to the Board, which describes any issues arising under the Code since the last report to the Board, including, but not limited to, information about material violations of the Code and action taken in response to the material violations.
VI. Other Policies and Procedures
This Code shall be the sole code of ethics adopted by the Fidelity Funds for purposes of Section 406 of the Sarbanes-Oxley Act and the rules and forms applicable to registered investment companies thereunder. Other Fidelity policies or procedures that cover the behavior or activities of Covered Officers are separate requirements applying to the Covered Officers (and others), and are not part of this Code.
VII. Amendments
Any material amendments or changes to this Code must be approved or ratified by a majority vote of the Board, including a majority of the Trustees who are not interested persons of the Fidelity Funds.
VIII. Records and Confidentiality
Records of any violation of the Code and of the actions taken as a result of such violations will be kept by the Fidelity Ethics Office. All reports and records prepared or maintained pursuant to this Code will be considered confidential and shall be maintained and protected accordingly. Except as otherwise required by law or this Code, such matters shall not be disclosed to anyone other than the Fidelity Ethics Office, the Personal Trading Committee, the Board, appropriate personnel at the relevant Fidelity company or companies and the legal counsel of any or all of the foregoing.
Exhibit EX-99.CERT
I, Stacie M. Smith, certify that:
1.
I have reviewed this report on Form N-CSR of Fidelity Commonwealth Trust II;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based upon such evaluation; and
d.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date:
April 21, 2020
/s/Stacie M. Smith |
Stacie M. Smith |
President and Treasurer |
I, John J. Burke III, certify that:
1.
I have reviewed this report on Form N-CSR of Fidelity Commonwealth Trust II;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based upon such evaluation; and
d.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date:
April 21, 2020
/s/John J. Burke III |
John J. Burke III |
Chief Financial Officer |
Exhibit EX-99.906CERT
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code)
In connection with the attached Report of Fidelity Commonwealth Trust II (the “Trust”) on Form N-CSR to be filed with the Securities and Exchange Commission (the “Report”), each of the undersigned officers of the Trust does hereby certify that, to the best of such officer’s knowledge:
1.
The Report fully complies with the requirements of 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Trust as of, and for, the periods presented in the Report.
Dated: April 21, 2020
/s/Stacie M. Smith |
Stacie M. Smith |
President and Treasurer |
Dated: April 21, 2020
/s/John J. Burke III |
John J. Burke III |
Chief Financial Officer |
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Trust and will be retained by the Trust and furnished to the Securities and Exchange Commission or its staff upon request.